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Résumé 
            L’estradiol (E2) est une hormone femelle qui joue un rôle essentiel, à la fois dans la 
régulation et dans la détermination de certaines conditions physiologiques in vivo, telle que la 
différenciation et la prolifération cellulaire. Lorsque l’E2 est donné en supplément, par 
exemple dans le cas de thérapie hormonale, deux effets sont observés, un effet génomique et 
un effet non-génomique, de par son interaction avec les récepteurs à œstrogène du noyau ou de 
la membrane cellulaire, respectivement. L’effet non-génomique est plus difficile à étudier 
biologiquement parce que l’effet se produit sur une échelle de temps extrêmement courte et à 
cause de la nature hydrophobe de l’E2 qui réduit sa biodisponibilité et donc son accessibilité 
aux cellules cibles. C’est pourquoi il est nécessaire de développer des systèmes 
d’administration de l’E2 qui permettent de n’étudier que l’effet non-génomique de 
l’œstrogène. Une des stratégies employée consiste à greffer l’E2 à des macromolécules 
hydrophiles, comme de l’albumine de sérum bovin (BSA) ou des dendrimères de type 
poly(amido)amine, permettant de maintenir l’interaction de l’E2 avec les récepteurs 
d’œstrogène de la membrane cellulaire et d’éviter la pénétration de l’E2 dans le noyau des 
cellules. Toutefois, ces systèmes macromolécules-E2 sont critiquables car ils sont peu stables 
et l’E2 peut se retrouver sous forme libre, ce qui affecte sa localisation cellulaire. L’objectif de 
cette thèse est donc de développer de nouvelles plateformes fonctionnalisées avec de l’E2 en 
utilisant les approches de synthèses ascendantes et descendantes. Le but de ces plateformes est 
de permettre d’étudier le mécanisme de l’effet non-génomique de l’E2, ainsi que d’explorer 
des applications potentielles dans le domaine biomédical.  
 L’approche ascendante est basée sur un ligand d’E2 activé, l’acide 17,α-
éthinylestradiol-benzoïque, attaché de façon covalente à un polymère de chitosan avec des 
substitutions de phosphorylcholine (CH-PC-E2). L’estradiol est sous forme de pro-drogue 
attachée au polymère qui s’auto-assembler pour former un film. L’effet biologique de la 
composition chimique du film de chitosan-phosphorylcholine a été étudié sur des cellules 
endothéliales. Les films de compositions chimiques différentes ont préalablement été 
caractérisés de façon physicochimique. La topographie de la surface, la charge de surface, 
ainsi que la rhéologie des différents films contenant 15, 25, ou 40% molaires de 
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phosphorylcholine, ont été étudiés par microscopie à force atomique (AFM), potentiel zêta, 
résonance plasmonique de surface et par microbalance à cristal de quartz avec dissipation 
(QCM-D). Les résultats de QCM-D ont montré que plus la part molaire en phosphorylcholine 
est grande moins il y a de fibrinogène qui s’adsorbe sur le film de CH-PC. Des cellules 
humaines de veine ombilicale (HUVECs) cultivées sur des films de CH-PC25 et de CH-PC40 
forment des amas cellulaire appelés sphéroïdes au bout de 4 jours, alors que ce n’est pas le cas 
lorsque ces cellules sont cultivées sur des films de CH-PC15. L’attachement de l’estradiol au 
polymère a été caractérisé par plusieurs techniques, telles que la résonance magnétique 
nucléaire de proton (1H NMR), la spectroscopie infrarouge avec transformée de Fourier à 
réfraction totale atténuée (FTIR-ATR) et la spectroscopie UV-visible. La nature hydrogel des 
films (sa capacité à retenir l’eau) ainsi que l’interaction des films avec des récepteurs à E2, ont 
été étudiés par la QCM-D. Des études d’imagerie cellulaires utilisant du diacétate de 
diaminofluoresceine-FM ont révélé que les films hydrogels de CH-PC-E2 stimulent la 
production d’oxyde nitrique  par les cellules endothéliales, qui joue un rôle protecteur pour le 
système cardiovasculaire. L’ensemble de ces études met en valeur les rôles différents et les 
applications potentielles qu’ont les films de type CH-PC-E2 et CH-PC dans le cadre de la 
médecine cardiovasculaire régénérative. L’approche descendante est basée sur l’attachement 
de façon covalente d’E2 sur des ilots d’or de 2 ȝm disposés en rangées et espacés par 12 ȝm 
sur un substrat en verre. Les ilots ont été préparés par photolithographie. La surface du verre a 
quant à elle été modifiée à l’aide d’un tripeptide cyclique, le cRGD, favorisant l’adhésion 
cellulaire. L’attachement d’E2 sur les surfaces d’or a été suivi et confirmé par les techniques 
de SPR et de QCM-D. Des études d’ELISA ont montré une augmentation significative du 
niveau de phosphorylation de la kinase ERK (marqueur important de l’effet non-génomique) 
après 1 heure d’exposition des cellules endothéliales aux motifs alternant l’E2 et le cRGD. Par 
contre lorsque des cellules cancéreuses sont déposées sur les surfaces présentant des motifs 
d’E2, ces cellules ne croissent pas, ce qui suggère que l’E2 n’exerce pas d’effet génomique. 
Les résultats de l’approche descendante montrent le potentiel des surfaces présentant des 
motifs d’E2 pour l’étude des effets non-génomiques de l’E2 dans un modèle in vitro. 
Mots-clés : estradiol, effet non-génomique, approches ascendantes et descendantes, substrats 
en micromotifs, chitosan, phosphorylcholine, oxyde nitrique, médecine cardiovasculaire 
régénérative, kinase régulée par signal extracellulaire 
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Abstract 
Estradiol (E2) is an essential female hormone in the regulation and determination of 
various physiological conditions in vivo, such as cell proliferation and differentiation. When 
supplementing exogenous E2 as a clinical strategy for hormone therapy, it generates genomic 
and non-genomic effect simultaneously via binding to the estrogen receptors in the cell 
nucleus or membrane site. Compared to the genomic effect, it is quite difficult to monitor the 
E2-induced non-genomic biological behavior because this effect occurs in extremely transient 
time scale and the bioavailability and accessibility of E2 to target cells is very low due to the 
hydrophobic nature of E2. As a result, it is indispensable to develop E2 delivery systems to 
specifically understand estrogenic non-genomic nature. One of strategies is to graft E2 to the 
hydrophilic macromolecules, e.g. bovine serum albumin (BSA) or poly(amido)amine 
dendrimer, to maintain E2 interacting with membrane estrogen receptors instead of penetrating 
into the cell nucleus. However, the instability of those E2-macromolecules systems, either 
containing free E2 leaching or discrepancies of cellular localizations, led to controversies. 
Herein, the objective of present thesis is to develop novel E2-functionlized platforms by the 
principle of bottom-up and top-down approaches for understanding the mechanism of 
estrogenic non-genomic effect, and further, to explore their potential applications in the 
biomedicine.  
As a bottom-up approach, an activated E2 ligand, 17α-ethinylestradiol-benzoic acid 
was covalently conjugated onto a phosphorylcholine substituted chitosan polymer (CH-PC-E2) 
as a prodrug strategy for the fabrication of self-assembled films. Through a series of combined 
physicochemical and cellular investigations, the relationship between various chemical 
compositions of chitosan-phosphorylcholine (CH-PC) films and cellular responses was also 
evaluated. Based on atomic force microscopy (AFM) examination, zeta-potential 
measurements, surface plasmon resonance (SPR), and quartz crystal microbalance with 
dissipation (QCM-D) measurements, surface topography, charge, and rheology of CH-PC 
films with 15, 25, and 40 mol% PC contents were characterized. Moreover, QCM-D 
measurements indicated that the amount of fibrinogen adsorbed on CH-PC films decreased 
significantly with increasing PC content. Finally, it was also showed that human umbilical 
vein endothelial cells (HUVECs)  form spheroids on CH-PC25 and CH-PC40 films, but not on 
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CH-PC15 films cultured over 4 days. In addition, the CH-PC-E2 polymer conjugates were 
prepared and characterized by several techniques, such as 
1
H nuclear magnetic resonance (1H 
NMR), Fourier transformed infrared-attenuated total refraction (FTIR-ATR) and UV/Vis 
spectra measurements. The hydrogel nature of CH-PC-E2 film as well as its interactions to 
estrogen receptors was further extensively investigated by QCM-D study. In the cellular study, 
CH-PC-E2 hydrogel films can significantly stimulate the production of nitric oxide, a 
protective molecule in the cardiovascular system, in the endothelial cells by a 
diaminofluorescein-FM diacetate imaging study. The studies above demonstrated the different 
roles and potential applications of CH-PC-E2 and CH-PC surfaces in the cardiovascular 
regenerative medicine. As a top-down approach, micropatterned substrates were used for E2 
functionalization, which were prepared by photolithography via aligning ~ 2 ȝm in diameter 
gold arrays onto a glass substrate. After that, a cell adhesive peptide, cyclic RGD was 
introduced to the glass surface in order to induce the attachment of cells. Meanwhile, estradiol 
was covalently immobilized on the gold surface and the process was monitored and validated 
by combining SPR and QCM-D studies. In the micropatterned substrate-coupled cell ELISA 
study, a phosphorylation level of extracellular signal-regulated kinase (ERK), which is an 
important non-genomic marker, was significantly elevated by this E2-functionalized 
micropatterned surface after 1 hour incubation. Furthermore, E2-functionalized 
micropatterned substrate didn’t proliferate cancer cells indicating the absence of genomic 
effect stimulation. Based on these results, our E2-functionalized micropatterned substrates can 
function as an in vitro model for the elucidation of estrogenic non-genomic behaviors.   
Keywords : estradiol, non-genomic effect, top-down and bottom-up approaches, 
micropatterned substrates, chitosan, phosphoylcholine, nitric oxide, cardiovascular 
regenerative medicine, extracellular signal-regulated kinase  
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CHAPTER ONE  
Introduction and Literature Review 
1.1 Estrogen in cardiovascular medicine 
1.1.1 Introduction to coronary artery heart disease 
Cardiovascular diseases (CVDs), which cover a variety of dysfunctions in tissues 
ranging from the cardiac muscle to the vascular system, are associated with a high rate of 
mortality and morbidity worldwide.
[1, 2]
 Coronary artery heart disease (CAHD), also known as 
atherosclerosis, is one of the most severe CVDs, and is characterized by the deposition of 
cholesterol and accumulation of plaque within the arterial wall.
[3]
 Epidemiological studies 
indicate that the causes of CAHD are diverse, including environmental influences (e.g. 
hormonal changes due to long-term smoking) and chronic physiological disorders (e.g. 
hypertension and diabetes).
[4]
 The long-term consequences of atherosclerosis may include 
thrombus formation, which can lead to an acute myocardial infarction.
[5]
Acute myocardial 
infarction can be fatal, as it leads to a reduction in the oxygen supply (perfusion) to the heart, 
as well as creating an abnormality in myocardial energy metabolism.
[6]
 To reduce the risk of 
myocardial infarction death, anticoagulant drugs, such as heparin
[7]
 and warfarin
[8]
, are widely 
prescribed in clinics. However, those drugs are associated with an increased risk of bleeding in 
some patients, which can lead to imbalanced hemostasis.
[9]
 Thus, there is currently an 
incentive to develop novel medical intervention strategies that reduce the incidence of 
CAHD.
[10]
 
Coronary artery bypass graft (CABG) surgery, percutaneous transluminal coronary 
angioplasty (PTCA), and endovascular stenting are current clinical strategies for the 
revascularization of atherosclerotic arteries and can significantly increase the life expectancy 
and quality of life for some patients.
[11, 12]
 For example, patients treated by CABG surgery had 
a significantly lower mortality than a control group, when comparing morality at 5 years 
(10.2% vs 15.8%), and 10 years (26.4% vs 30.5%) post-intervention.
[13]
 At 12 months, the 
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rates of death and myocardial infarction were similar between the CABG and percutaneous 
coronary intervention (PCI), patients, but stroke was significantly more likely to occur with 
CABG (2.2% vs. 0.6% with PCI).
[14]
 However, adverse cardiac complications were 
significantly higher in the PCI group (17.8%, vs. 12.4% for CABG), likely because of an 
increased rate of repeat revascularization. In conjunction with surgical treatment, novel 
medical devices (e.g. artificial heart valve or stent) are also being developed for the 
amelioration of these cardiovascular diseases, which will greatly enhance the 
quality of patients' lives.
[15]
  
1.1.2 The anatomy and physiology of blood vessels 
One of the therapeutic targets of coronary artery heart disease is the blood vessel, 
which is the main part of the circulatory system for nutrients and oxygen transportation 
throughout the body. They are classified as arteries, capillaries, and veins.
[16]
 The inner wall of 
the blood vessels is lined with endothelial cells. These endothelial cells comprise the 
endothelium, which provides a mechanical barrier against the circulating blood. They also act 
as an interface that can sense alterations in blood flow and plasma constituents, as well as 
secrete a variety of powerful chemical mediators that regulate vascular remodeling.
[17]
 In 
contrast, smooth muscle cells are located principally along the outer layer of the endothelium. 
They are also involved in biochemical vaso-regulatory processes, but in a far less efficient 
manner than endothelial cells.
[18]
 Interactions between endothelial cells and smooth muscle 
cells are crucial to determine various pathophysiology of cardiovascular systems, including 
arteriogenesis and atherosclerosis
[19]
  
Nitric oxide (NO) is a gaseous free radical cellular messenger generated by three types 
of nitric oxide synthases (NOS): neuronal (nNOS), inducible (iNOS) and endothelial NOS 
(eNOS).
[20]
 NO is an important signal molecule produced by endothelial cells, serving to 
inhibit platelet aggregation, leukocyte adhesion, and smooth muscle cell proliferation.
[21] 
Moreover, NO is recognized for its protective role within the vasculature by preventing 
biochemical cascades leading to thrombus formation.
[22]
 For example, it has been shown that 
NO exerts a protective effect on vasculature through inhibiting platelet aggregation in a 
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transgenic mouse model. Blood clotting time was markedly decreased in eNOS-deficient 
versus wild-type mice (77±3 versus 133±3 seconds).
[23]
 
1.1.3 Estrogen effects on the cardiovascular system 
17β-estradiol (E2) is a female hormone produced by human ovaries that controls and 
regulates several physiological conditions. Synthetic estradiols are used in contraception and 
in hormonal replacement therapy (HRT) for menopausal women.[24] For example, ethinyl 
estradiol (EE2), which mimics the endocrine properties of E2, is used in oral contraceptive 
formulations such as Norlestrin, Brevicon, and Ortho–Novum.[25] As such, estradiol plays 
critical roles in female sexual maturation and reproduction by initiating epithelial proliferation 
of the vagina, uterus, and breast.[26] It has been observed that the incidence of cardiovascular 
disease differs significantly between men and women, or between premenopausal women and 
postmenopausal women. This fact hinted that E2 may confer cardio-protective effects in 
addition to its hormonal functions.[27, 28] In cardiological studies, E2 has been shown to 
decrease the development of atherosclerosis and to elicit protection against ischemia by 
directly exerting the effects within the blood vessels.[29] Moreover, it has been reported that the 
local delivery of E2, via either an infusion catheter [30-32] or phosphorylcholine-coated stent, 
inhibited neointimal proliferation in coronary arteries following stent implantation.[33]  
1.1.4 Estrogen receptors and classical genomic effect 
E2 acts as a mediator via binding estrogen receptors (ERs).[34] ERs exist in two main 
forms, ERα and ERβ, encoded by two genes, ESR1 and ESR2, respectively, that are 
discovered at different chromosomal locations.[35] E2 passively diffuses into the cells where it 
binds to ERs in the nucleus.[36] Once bound, the estrogen receptor dimerizes and converts to an 
activated form. The dimerized ERs bind estrogen response elements (EREs) in the enhancer 
regions of estrogen-responsive genes, thereby activating the transcription of estrogen-
inducible genes.[37] This phenomenon is regarded as a genomic effect or nucleus effect.[38] It is 
also interesting to note that this effect has also been shown to promote the proliferation, 
angiogenesis, and metastasis of tumor cells, which causes non-negligible adverse effect.[39] 
There are multiple pathways to induce this genomic effect:[40] A) E2-nucleus ER complexes 
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bind to estrogen receptor elements (EREs) at the promoter regions of target gene, thereby 
inducing their expressions (ERE-dependent genomic pathway). B) E2-nucleus ERs complexes 
bind to transcription factor complexes (ERE-independent genomic pathway). C) Instead of E2, 
growth factors themselves are also able to activate multiple kinase cascades and induce 
phosphorylation of nuclear estrogen receptors (Growth factor-dependent genomic pathway). 
1.1.5 Estrogen non-genomic effect  
E2 can trigger several alternative pathways via direct or indirect signal transduction 
rather than through the genomic effect. These pathways are regarded as the non-genomic 
effects[41] that are initiated on either the membrane or the cytosolic sides of the cell (Figure 
1.1).[38] E2-elicited non-genomic effects are very rapid (seconds to minutes) in comparison to 
the activation of genomic-mediated effects (hours to days).[42]  
 
 
Figure 1.1 Schematic representation of the genomic and nongenomic estrogen pathways. For 
the genomic pathway, E2 (red triangle) crosses the cell membrane and binds to the estrogen 
receptor (ER) in the cell nucleus, inducing gene transcription. For the non-genomic pathway, 
E2 interacts with ER or ER/GPR30 on the cell membrane, which activates several transduction 
pathways (Figure taken from [43]). 
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Extracellular-signal-regulated kinase (ERK), a component of the mitogen-activated 
protein kinase (MAPK) family, and AKT kinase, a component of the phosphatidylinositol-4, 
5-bisphosphate 3-kinase (PI3K) family, are involved in E2-mediated responses.[42, 44-47] In the 
ERK/MAPK pathway, the E2-induction is associated with several phosphorylation 
cascades.[48, 49] The majority of studies in MCF-7 cells reported the activation of ERK1/2 by 
E2 ranging from 2 to 15 min of its activity.[48, 50-53] But, some studies under similar conditions 
described E2 leading to elevations in ERK1/2 activity only after 2 h of induction, with 
persistent activation for up to 1 day.[54, 55] The difference in these results might originate from 
the differed cell culture methods. In the PI3K/AKT pathway, E2 leads to the release of nitric 
oxide (NO),[56] cyclic amines (cAMP, cGMP)[57, 58] and calcium[59] in a variety of cell types. 
Moreover, E2-induced non-genomic effects trigger the activation of phospholipase C 
(PLC)/protein kinase C (PKC) signal transduction pathways.[60] The cell signal pathways 
triggered by E2 non-genomic effects are summarized in the Table 1.1. 
Table 1.1 Summary of the E2 non-genomic effects 
Signal pathway Time E2 dose Analyzed 
Protein 
Cell line 
 
PI3K/AKT[56] 
 
 
5 to 30 mins 
 
25 nM 
 
PI3K/AKT and 
eNOS 
 
HUVEC 
 
PI3K/AKT[61] 
 
 
15 mins to 2 hrs 
 
1 ȝM 
 
PI3K/AKT 
 
Endometrial 
cancer cells 
 
PI3K/AKT[62] 
 
 
0 to 60 mins 
 
10 nM 
 
 
PI3K/AKT 
 
HepG2 cells 
 
ERK/MAPK[50] 
 
 
15 min to 1 day 
 
1 ȝM 
 
pERK 1/2 
 
 
HepG2 cells 
 
ERK/MAPK[51] 
 
 
2 min to 2 hrs 
 
10 nM 
 
pERK 1/2 
 
MCF-7 cells 
 
ERK/MAPK[52] 
 
 
15 min 
 
10 nM 
 
pERK 1/2 
 
MCF-7 cells 
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            It has also been hypothesized that E2 exerts non-genomic actions by interacting 
directly with growth factor receptors.[63] This process is directed through E2-mediated tyrosine 
kinase’s activation of growth factor receptors, such as the epidermal growth factor receptor 
(EGFR).[64, 65] The activation of growth factor receptors, in turn, triggers downstream cell 
signal transduction cascades such as MAPK.[49, 66] 
            Other studies reported that the E2-induced non-genomic effect was mediated through a 
G protein-coupled transmembrane receptor, GPR30.[67] Recent studies have also implicated 
GPR30 as a potential candidate for the activation of membrane-initiated estrogen signaling.[68] 
Supporting this claim, it has been demonstrated that GPR30 increased both ER-α and EGFR 
activities in patients undergoing clinical treatment for breast cancer.[69] However, the 
assumption, that GPR30 is responsible for an E2-mediated non-genomic effect is still under 
dispute.[63]  
1.1. 6 Tools for estrogen non-genomic effect study 
            Estrogen conjugated to membrane-impermeable proteins, e.g. E2-BSA, have been used 
to determine the non-nuclear ER actions in various cell types.[70-72] However, freshly prepared 
solutions of E2-BSA always contain free E2 which cannot be fully removed during the 
synthesis process. Moreover, E2-BSA binds to the ER only poorly because certain E2-BSA 
preparations are of very high molecular weight, suggesting extreme high steric hindrance.[73] 
Last, but maybe not least, E2-BSA is readily degraded by the cell, making long-term 
experiments problematic and in vivo studies impossible.[74]  
            Recently, an estrogen dendrimer conjugate (EDC) has been prepared for the 
stimulation of membrane-mediated non-genomic effects.[75] Such E2-dendrimer systems also 
activated vascular endothelial cell migration, which could regulate the processes of 
cardiovascular protection without enhancing growth of breast cancer cells.[76] Nonetheless, 
confocal microscopic studies showed that EDC can also penetrate into cytoplasmic sites at 
MCF-7 cells. As a result, a detailed profile of an estrogen-initiated short-term signaling 
pathway has not been elucidated yet as using the estrogen conjugate systems.  
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1.2 Polymeric biomaterials in cardiovascular medicine 
1.2.1 Fundamental properties of polymeric biomaterials 
            Polymeric biomaterials are widely developed for in vitro and in vivo applications to 
study complex biological phenomena.[77] The essential design criteria for polymeric 
biomaterials are related to their high-quality performance, structural and functional stability, 
and physiological compatibility.[78] To date, various polymeric materials have been tested for 
the preparation of biomaterials, these include polystyrene,[79] poly(methyl methacrylate) 
(PMMA),
[80]
 polydimethylsiloxane (PDMS),[81] and polyurethane.[82] For example, PMMA is a 
transparent polymer commonly known as Plexiglass.
[83]
 Thin films of PMMA can be modified 
by aminolysis reaction to introduce amine groups,
[84]
 which can confer resistance against non-
speciﬁc protein adsorption.[80] PDMS is the most commonly used material for the preparation 
of microﬂuidic devices due to its elastomeric properties and ease in molding.[85] PDMS micro-
fabricated surfaces were prepared as a synthetic cornea in an attempt to stimulate stromal 
restoration.[86] Once the polymeric biomaterials are placed into the biological environment, 
many factors should be considered: surface charge, surface topology, surface energy and 
chemistry, to name a few.[87] Therefore, it is critical to develop cost-effective and efficient 
approaches to understand the physical properties of polymeric biomaterials, and to widen the 
design parameters for suitable constructs. 
1.2.2 Mechanical properties 
In order to provide an appropriate microenvironment for supporting cells or entire 
tissues in vitro and in vivo, biomaterials should have reliable mechanical properties.[87, 88] 
Generally, once biomaterials enter in contact with living organisms, deformation of 
biomaterials or cells will occur due to forces exerted by external environment, e.g. blood 
stream. The elastic modulus (or modulus of elasticity) is a constant that define quantitatively 
the ability of a biomaterial to resist deformation under external force as well as to recover the 
initial state after removal of the force, including Young's modulus and shear modulus. 
Young’s modulus is usually expressed as E, representing the elastic resistance of objects to 
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tensile strength e.g., elongation or compression. Young’s modulus can be calculated by 
following equation (1): 
     � = ��                                                                                             (1)                   
where E is the Young's modulus, � is the tensile strength, � is the extensional strain.  
Shear modulus is usually expressed as G, representing the resistance of objects to 
deformation in shear. The relation between shear modulus (G) and Young’s modulus can be 
expressed as following equation (2):  
      � = �ଶሺଵ+ѵ ሻ                                                                                    (2)                            
where E is Young’s modulus, ѵ is Poisson's ratio.[89-92] 
Moreover, some soft biomaterials, such as hydrogels, exhibit both viscous and elastic 
characteristics, which are recognized as viscoelasticity. Viscoelasticity is composed of the 
storage modulus G’, which defines the elastic property of materials and the loss modulus and 
G”, which governs the viscous property of materials.[93-96] Both Gƍ and GƎ can be 
characterized by a power-law frequency dependence with critical exponents α and β, 
respectively (Gƍ ∝ f α and GƎ ∝ f β). Knowing the viscosity of material η(f), the loss modulus 
can be calculated based on the equation (3):  
GƎȋfȌ = 2πf ηȋfȌ.[97]                                                                                                   (3) 
Polymeric biomaterials have a wide range of elasticity values (E or G’) from a few Pa 
to hundred MPa in a similar range of tissue or organs in vivo, which could offer various 
choices for the biomedical applications.[98] For example, the elastic modulus of synthetic PEG 
is in a range of a few kPa, and could be used to prepare extra cellular matrices (ECMs) to 
support cell and tissue growth in a three dimensional manner.[99, 100]. By tuning the elastic 
modulus of polyacrylamide gel based substrate from 1 kPa to 100 kPa, adult human 
mesenchymal stem cells (hMSCs) differentiate into neuron, muscle, or osteogenic cells, 
respectively.[101] Thus, a substantial understanding of the intrinsic mechanical properties of 
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polymeric biomaterials will facilitate the design and development of functional biomaterials 
more efficiently. 
1.2.3 Biodegradability  
The term of biodegradation is generally defined as the breakdown of the polymer 
materials by the hydrolytic or enzymatic cleavage reactions.[102] For tissue engineering 
applications, it is desirable to develop biodegradable polymer materials with predictable 
erosion kinetics. Hydrolysis is a major degradation mechanism in vivo that degrades larger 
polymer chains to smaller chains or monomers.[103] The effect of pH is critical in this 
hydrolytic process.[104] For example, polylactide (PLA) polymers have the slowest hydrolysis 
rate at pH~4.[105] Enzymatic cleavage is another important mechanism for polymer 
degradation.[106] The rate of in vivo enzymatic degradation of polymers depends on the 
distribution and concentration of the cleavage enzymes.[107] In most of cases, hydrolytic and 
enzymatic cleavage reaction occurs simultaneously.[108]  
Both natural and synthetic polymers have been extensively investigated as 
biodegradable biomaterials. Natural polymers are promising due to their susceptibility to in 
vivo degradation.[109] For example, cellulose is a main composition of plants and natural fibers, 
which is degradable by several microorganisms. Cellulose-based hydrogels can facilitate the 
scarless healing processes upon degradation.[110] Synthetic polymers also demonstrate 
biodegradability and easily undergo chemically-tailored reactions for specific biomedical 
applications.[111] For example, by grafting PEG to a synthetic biodegradable polycarbonate, the 
degradation takes place within one day. It may be useful in clinical applications ranging from 
cosmetic surgery to cancer treatment.[112] As a consequence, investigations into polymeric 
materials will help to develop safe and environment friendly products by taking advantage of 
their biodegradable properties. 
1.2.4 Cellular interactions  
The interactions between cells and implanted biomaterials, especially cell adhesion to 
surfaces, are determined by the nature of biomaterials.[113] When deposited on an adhesive 
substrate, cells are favorable to be spread out. As given a certain time, the cells proliferate and 
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form a two-dimensional monolayer. However, when the spreading of cells is unfavorable, e.g. 
in the case of non-adhesive surfaces, cells spontaneously move by active cell motility and 
eventually meet to form compact clusters and three-dimensional aggregates (spheroid).[114, 115] 
The forces influencing cell adhesion include:  
            (1) Surface energy interaction. The primary factor of cell adhesion to the surface relies 
on the balance of surface energy, e.g. surface hydrophobicity and hydrophilicity.[116] 
Generally, surfaces with high-energies are able to enhance cell adhesion compared with 
surfaces with low-energies.[117] As a result, surfaces with high-energies are usually used for 
the cellular adhesion.  
            (2) Electrostatic interaction. Because a major part of the cell membrane is negatively 
charged, the surface charges of the biomaterial surfaces are usually designed to be positive to 
ensure cell adhesion.[118]  
            (3) ECM protein interaction. ECM proteins, such as fibronectin, can easily adsorb onto 
the biomaterial surfaces due to their wide-spread existence in vitro and in vivo environments, 
suggesting that the influence of these proteins is also predominant in the process of cell 
adhesion.[119, 120] 
Functionalized surfaces that are able to induce, in a predictable way, cell adhesion will 
be useful. For example, a thermosensitive polymer poly (N-isopropylacrylamide) (PNIPAM) 
is able to undergo phase transition from hydrophilic to hydrophobic by tuning the temperature 
from room temperature to physiological conditions (~37 °C). [121] PNIPAM was recently used 
to prepare thermosensitive functionalized surfaces for harvesting cells in a confluent 
monolayer. This novel cell culture platform allows formation of cell monolayers in an 
environment that is more relevant to the real-life situation and hence transplantation-favorable 
to host tissues.[122, 123] To sum up, controlling the cellular responses, e.g. cell adhesion or cell 
spread, to biomaterials is a fundamental step in biomaterial research. 
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1.3 Non-fouling polymeric biomaterials in cardiovascular 
regenerative medicine 
1.3.1 Overview of non-fouling polymeric biomaterials 
Non-specific protein (e.g. fibrinogen, fibronectin, and vitronectin) adsorption [124] and 
blood cell adhesion[116] onto a biomaterial surface triggers a foreign body reaction which can 
lead to detrimental consequences.[125] This process is known as biofouling or fouling.[116] Non-
fouling is the term used to define the ability of a material to resist non-specific protein 
adsorption and blood cell adhesion in vivo and hence to not cause adverse effects when they 
are placed in contact with living organisms.[126] Several properties of polymeric materials, 
such as their composition, hydrophobicity/hydrophilicity, charge, and topology are responsible 
for biocompatibility.[127] The origin of the non-fouling characteristic of a polymeric 
biomaterial is due to the formation of a highly hydrated layer near the surface, which generates 
an energetic barrier to prohibit immune responses occurrence.[128, 129] The mechanism of non-
fouling characteristic of polymeric materials can be explained as follows. Briefly, the polar 
groups of proteins can form hydrogen bonds with the surrounding water medium. However, if 
the surface of polymeric materials (e.g. PEG) is very hydrophilic, the water molecules can 
penetrate into the polymers to form a net-like structure, which is regarded as the “surface-
bound” water. Meanwhile, both the protein and material surface tend to expulse water 
molecules to facilitate protein adsorption, which generate physical and energetic barriers (also 
known as dehydration entropic effects).[126, 130] The non-fouling characteristic of polymeric 
materials is fundamentally determined by numerous factors, i.e. film thickness and packing 
density or chain conformation and flexibility.[130] As a result, non-fouling characteristic is 
certainly one of the most significant characteristics of biomaterials, when considering their 
practical biomedical applications.  
Poly (ethylene glycol) (PEG), zwitterionic-based materials, and some polysaccharides 
are among the most widely used non-fouling materials (summarized in the Table 1.2).[131, 132] 
PEGylated materials are the most commonly used biomaterials due to their highly hydrophilic 
and flexible nature. As introduced previously, a water barrier can be generated between PEG 
and proteins to entropically impede non-specific adsorption occurrence.[128] Moreover, the 
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high chain flexibility of PEG yields compression of chains and hence sterically repulses 
protein adsorption.[133] The end of PEG can be tailored by different functional moieties, such 
as thiol, amine, and carboxylic acid, for the different biological applications.[130] For example, 
thiol end functionalized PEG enables its immobilization onto gold surfaces and the thickness 
of the PEG layer is correlated with the response to the biological environment.[134] 
Zwitterionic-based materials, such as phosphorylcholine, sulfobetaine, and carboxybetaine 
derivatives (structures shown in Fig. 1.2), possessing covalently linked cationic and anionic 
groups,[135] are known to reduce non-specific protein adsorption and inhibit cell adhesion.[136, 
137]
 Phosphorylcholine (PC) is present on phospholipids of the outer layer of the cell 
membrane. It has an excellent ability to reduce nonspecific protein adsorption.[138] The key 
factors, e.g. hydration and ionic solvation, leading to the non-fouling behavior of PC were 
determined by molecular simulation techniques.[139] Similar to phosphorylcholine, both 
sulfobetaine (SB) and carboxybetaine (CB) also showed strong anti-fouling capacities.[140, 141] 
When poly-(sulfobetaine) was grafted onto a poly-(ether urethane) surface by atom-transfer 
radical-polymerization(ATRP), the surface exhibited extremely low fibrinogen adsorption.[142]  
 
Figure 1.2 Chemical structures of zwitterionic-based materials. (A) phosphorylcholine (PC), 
(B) sulfobetaine (SB), and (C) carboxybetaine (CB). 
            The natural polysaccharide heparin, a potent anticoagulant, has shown promising 
biomedical applications due to its antimicrobial and anti-inflammatory capacities.[143-145] It is a 
glycosaminoglycan consisting of a sulfated disaccharide repeat unit (Fig.1.3A). The most 
common disaccharide unit is composed of a 2-O-sulfated iduronic acid and 6-O-sulfated, or N-
sulfated, glucosamine.[146] The molecular weight of heparin ranges from 4 to 40 kDa.[147] 
Heparin, which is a polyanion, adopts an extended conformation in vivo.[148, 149] Heparin-
coated surfaces showed a good biocompatibility, which decreases the incidence of restenosis 
(A) (B) (C)
 13 
 
and  reduces thrombogenesis and inflammatory reactions.[150] Hyaluronic acid (HA) is anionic 
polysaccharide, composed of D-glucuronic acid and D-N-acetylglucosamine, linked via 
alternating β-1,4 and β-1,3 glycosidic bonds  (Fig. 1.3B).[151] The molecular weight of HA 
ranges between 100 kDa to 8000 kDa in vivo.[152] The glucuronic acid, carboxylic acid, the 
primary and secondary hydroxyl, and the N-acetyl groups of HA can be chemically modified 
for conjugating different moieties in order to prepare HA-based hydrogels.[153] HA hydrogels 
can promote the proliferation and migration of mesenchymal cells and enhance the 
endogenous tissue repair process.[154] The ultralow protein adsorption of HA is also 
demonstrated by surface plasmon resonance (SPR) (only 0.6−16.1 ng/cm2).[155] Chitosan is a 
cationic polysaccharide extracted from N-acetylation of chitin.[156] It has been studied for 
applications in several fields,[157] such as wound healing,[158] drug delivery,[159] gene 
therapy,[160] and tissue engineering.[161] It is a linear polycation composed of β-D-glucosamine 
and β-D-N-acetylglucosamine residues in 1→4 linkages (Fig. 1.3C). [162] It is soluble in acidic 
solutions, but it is poorly soluble in neutral pH conditions.[163] Moreover, the solubility of 
chitosan is highly associated with degradability, which is decided by its physical and chemical 
properties, such as deacetylation and molecule weight.[164] For instance, deacetylation can not 
only affects the degradation rate, but also enhance the solubility of chitosan at neutral pH.[164, 
165]
 The molecular weight also affects chitosan solubility.[166] If chitosan was degraded into 
low molecular weight chitosan (LMWC) with the molecular weight below 10Da, the water 
solubility of chitosan largely increased.[167] The non-fouling nature of chitosan was also 
widely acknowledged. In a previous study, it was also demonstrated that chitosan nanocoating 
protects against adsorption of BSA, TGF-β1 and human plasma due to its surface 
hydrophilicity.[168] Chitosan has also been developed as scaffold for wound healing purposes 
because of its antibacterial activity.[169] By using heparin /chitosan blended films, such 
antibacterial activity was further enhanced.[170] Besides its biodegradability and non-fouling 
features, chitosan also has cell adhesive properties as a artificial component of the 
extracellular matrix.[171] Chitosan films are known to support cell adhesion, as has been 
observed in the cases of dorsal root ganglions,[172] keratinocytes, and fibroblasts.[173]  
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Take these facts together, non-fouling materials should be extensively used in the 
cardiovascular regenerative medicine in order to produce neither inflammatory nor immune 
responses, while retaining the capacity of cell adhesion.  
 
 
Figure 1.3 Chemical structures of natural polysaccharides. (A) heparin, (B) chitosan, and (C) 
hyaluronic acid. 
 
 
 
 
 
 
 
 
 
 
 
(A)
(B) (C)
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Table 1.2 Summary of non-fouling materials 
Polymer Preparation 
method 
Surface 
characterization 
method 
Method to assess 
biocompatibility 
 
PEG[134] Self assembled 
monolayer 
Ellipsometry, AFM 
 
Endothelial cells adhesion 
kinetics study 
PEG-block- 
polycarbonate[174] 
Covalently 
immobilization 
QCM-D, SEM Bacterial viability assay, 
platelet adhesion study, 
static hemolysis assay 
 
Catecholates anchored 
PEG[175] 
Chemical 
deposition 
Ellipsometry Human blood assay, bone-
derived stromal cells, 
bacterial adhesion 
PC[135] Self assembled 
monolayer 
XPS, ellipsometry, 
SPR 
Human Fg and BSA 
adsorption study 
Poly(sulfobetaine 
methacrylate)[176] 
Chemical 
deposition 
ATR/FT-IR, XPS, 
SEM 
BSA adsorption study 
 
Carboxybetaine[177] 
Self assembled 
monolayer 
Contact angle 
measurement, 
XPS,QCM-D 
BSA adsorption and blood 
cell adhesion study 
Carboxybetaine graft 
polysiloxanes  
(PDMS-g-CB)[178] 
Chemical 
deposition 
ATR/FT-IR, XPS, 
SEM, contact angle 
measurement 
BSA, Hgb and lysozyme 
adsorption study 
HA[155] Covalently 
immobilization 
Contact angle 
measurement, 
AFM, SPR 
BSA, lysozyme and 
soybean milk adsorption 
study 
Chitosan[168] Physical 
adsorption 
SEM, AFM, MTT 
viability test. 
BSA, human blood 
adsorption study 
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1.3.2 Non-fouling polymeric biomaterials in cardiovascular regenerative 
medicine 
Implantable biomaterials or blood contact devices are widely used to cure 
cardiovascular diseases or alleviate symptoms.[179] One such example is the cardiovascular 
stent. Revascularization procedures, such as a coronary balloon angioplasty, are often 
accompanied by various complications (e.g. restenosis).[180] The introduction of a stent into an 
artery after angioplastic surgery can expand blood vessels and restore blood flow through 
narrowed arteries.[181]. Silicone rubber or plastic was initially used to support the blood vessels 
in order to maintain the intravascular blood flow.[182] Stainless steel AISI 316L[183] or titanium 
(Ti)[184], possessing exceptional corrosion resistance and mechanical properties, are the 
commonly used medical metals for cardiovascular stent nowadays. However, it is widely 
acknowledged that dominant side effect can be induced by these bare metal stents (BMS), e.g., 
late in-stent restenosis, a phenomenon that reoccurs of angina.[185, 186] Recently, synthetic or 
natural polymer coated drug-eluting stents have proven to be superior to BMS in many 
respects.[187, 188] They are able to reduce significantly the incidence of restenosis by locally-
controlled release of drugs to the neointimal and inflammatory areas.[189] In order to be usable, 
the polymer coating material must support the vessel lumen to maintain its patency, and 
naturally degrade within a certain time. Nowadays, two types of commercially available DESs 
are available (Cypher® and Taxus®) which are the most widely used in the clinical setting. 
They have embedded anti-proliferative agents (Rapamycin in the case of Cypher®
[190]
 and 
paclitaxel in the case of Taxus®
[191]
 ) with hydrophobic polymer surfaces. However, both 
Cypher® and Taxus® have some drawbacks. For example, they use durable thick polymers 
((polyethylene vinyl acetate (PEVA)/ poly(butyl methacrylate (PBMA) for Cypher® and 
poly(styrene-b-isobutylene-b-styrene) for Taxus®).[192] As a result, new generation of polymer 
coated stents are still highly in demand. A PEG-coated titanium surface shows excellent blood 
compatibility by resisting platelets and leukocytes adhesions.[193] In a porcine coronary 
restenosis model, grafting PEG to the biodegradable polymer poly(D, L-lactide-co-glycolide) 
(PLGA), significantly inhibited neointimal hyperplasia 1 month after of implantation.[194] 
Phosphorylcholine (PC) and sulfobetaine (SB) are also attracting attention as new generation 
of stent coating materials. Recently, a PC and SB derivative materials coated magnesium alloy 
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surface demonstrated promising results in the reducing acute thrombotic responses.[195] 
Especially, PC-coated stent is extensively studied both in pre-clinical and clinical trials. In the 
mid-term (6 months) results, the symptoms of acute myocardial infarction of the patients were 
also significantly alleviated after implanting PC-coated stent.[196] The reliability of PC-coated 
stents was also validated in the long-term assessment.[197]  
Another example of polymeric materials being used in cardiovascular medicine is 
vascular grafting. In arterial bypass procedures, synthetic polymers are widely used to redirect 
blood flow in the specific site of the body and have shown an excellent 5 year survival rate for 
the patients (exceeding 95 %).
[198]
 The approach for reconstructing and remodeling tissues is 
to recruit autologous endothelial cells (EC) or endothelial progenitor cells (EPC) after 
implantation of the graft and to promote similar neovascularization to a native vessel by 
supporting local angiogenesis.
[199, 200]
 This in situ endothelialization of a vascular graft 
following implantation is a promising solution for enhancing graft patency rates.
[201]
 
Commercially available synthetic vascular graft materials are either expanded 
polytetrafluoroethylene (ePTFE) or poly(ethylene terephthalate) (Dacron).
[202]
 In some cases, 
the diameter of grafts should be as small as possible, in order to reach the target vessel site 
through narrow vasculature. However, these materials are not suitable for smaller-diameter 
(with internal <6 mm) tubes used in vascular bypass surgery, resulting in a high rate of graft 
failure.
[203]
 The major reason is that they increase the risk of thrombus due to their low 
biocompatibility.[204] In this aspect, non-fouling polymer coating surfaces can be utilized as an 
alternative. For example, the PEG was grafted onto poly-(ethylene terephthalate) (PET) and 
greatly improved hemo-compatibility of the PET surfaces.[205] In addition, the PEG grafted 
PET was prepared to generate polymer brushes via a surface-initiated atom-transfer radical 
polymerization method and showed an excellent anti-fouling effect during the platelet 
adhesion assays.[206] In a porcine model, grafting PEG to poly (propylene sulphide) effectively 
reduced thrombogenicity and enhanced the graft patency of small diameter vascular grafts.[207] 
In the clinical trial, PEG-hirudin/iloprost coated PTFE based small diameter grafts inhibited 
the progress of pseudointima and intimal hyperplasia in the patient as well.[208]  However, in 
vitro regular 2-dimensional vascular graft based endothelialization is usually initiated by using 
cellular monolayer.[209] Unfortunately, the efficacy of 2-dimensional vascular graft for the 
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tissue rebuilding shows distinctive low-efficiency features compared to in vivo conditions, as 
endothelial cells are prone to apoptosis with respect to lack of oxygen and nutrition supply 
after engraftment in tissues.
[210]
 In an effort to narrow the gap between in vitro and in vivo 
conditions, polymeric substrates have been developed to culture endothelial cells as  multi-
cellular 3D spheroids, in which the cells grow into a small capsule-like shape.[211] The 
advantages of such 3D spheroids cell culture have been well-acknowledged due to they can 
better mimic the real in vivo physiological conditions and they are currently being explored 
with the goal of developing efficient 3D vasculature or micro-vessel formation in vivo as 
well.[212-214] 
            Polysaccharide-based materials also played vital roles in cardiovascular regenerative 
medicine in terms of cardiac cell injection delivery system or implantable scaffold 
strategy.[215] Among them, hydrogels composed of hyaluronic acid (HA) were shown to induce 
neovascularization and enhance cardiac function in an animal model of myocardial 
infarction.[216] However, the poor performance of HA in terms of mechanical properties limits 
its direct clinical application.[217] In order to resolve this issue, varying amounts of 
methacrylate substitution of HA hydrogels were carried out conferring varied mechanical 
properties were injected into the heart.[218] Moreover, anionic polymer HA and cationic 
polymer chitosan were deposited by a layer-by-layer assembly approach for the preparation of 
polyelectrolyte multi-layers and used in the regeneration of blood vessels.[219] The excellent 
biocompatibility of these polyelectrolyte multi-layers enables the inhibition of blood clots on 
damaged arterial walls.[220] Further, the excellent mechanical performance of HA/chitosan 
multi-layers along with their high water content exhibited strong resistance against platelet 
adhesion.[183] In future, developing new-generation intelligent interfaces for cardiovascular 
regenerative medicine, e.g. a micro-fabricated polymeric scaffold that dynamically controls 
the cell’s microenvironment in three dimensions and hence mimicks physiological conditions 
in a more real life manner, would be the next aim.[221, 222] 
1.4 Methods and Techniques 
In order to study physical chemistry properties of surface functional biomaterials, 
surface analytical tools with high sensitivities, such as SPR or QCM-D, are widely used to 
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detect the polymer/protein adsorption kinetics in real time. Those techniques are flexible to 
provide additional mechanical and biologically relevant information of biomaterials, which 
can mimic their interactions to bio-organisms under real physiological conditions. Moreover, 
some micro/nanotechnologies based techniques, such as photolithography, contributed to 
fabricate surface functional biomaterials in desired shapes or geometries, leading us to a better 
understanding of surface functional biomaterials’ fundamental mechanisms. Herein, SPR, 
QCM-D and photolithography will be introduced as following sections. 
1.4.1 Surface plasmon resonance technology (SPR) 
            Surface plasmon resonance technology (SPR) is a label-free analytical technique with 
high sensitivity to monitor biomolecular interactions in real-time.[223] It is widely used for the 
study of dynamic binding characteristics between receptor/ligand or antibody/antigen in the 
clinical diagnosis, gene sequencing, proteomics, cell signaling, drug screening, and 
environmental science.[224] 
            When a polarized incident light hits a metal interface at a certain critical angle, the 
total internal reflection occurs to the excitation of surface plasmon within the metal 
interface.[225] At the moment of surface plasmon resonance occurs, most of the incident light 
photons are absorbed, while the energy is transferred to the electrons. In the reflected light 
intensity response curve, a small peak could be observed corresponding to SPR minimum 
resonance angle, m.[226] When specific molecule adsorption occurs on the metal surface, 
changes of SPR minimum resonance angle is accordance with the changes of refractive index 
of the metal surface, which are proportional to the molecular mass bound to the substrate. [227]  
In 1983, Liedberg et al., firstly applied SPR technology to analyze antigen-antibody 
interaction.[228] In 1990, SPR was commercially available and used as a standard analytical 
tool in life sciences and pharmaceutical research.[229] Nowadays, SPR technology has been 
extended to the study of binding kinetics of biological molecules interactions, such as protein-
protein/DNA,[230] drug molecule-target proteins[231] and other biological molecules. SPR also 
plays a vital role in monitoring estrogen biology. For instance, Rich et.al systematically 
investigated the binding affinity between ER-α and E2 with its derivatives by SPR.[232] SPR 
also was used to detect the presence of E2 in the water environment by immobilization of ER-
α to a gold substrate as a biosensor.[233] 
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1.4.2 Quartz crystal microbalance with dissipation (QCM-D) 
Quartz crystal microbalance with dissipation (QCM-D) is a cost-effective and high-
resolution analytical technique to measure the surface mass changes caused by the specific 
adsorption of target molecules by the principle of piezoelectric effect of quartz crystal.[234] 
When an external voltage is applied on the quartz crystal sensor, the quartz crystal will 
oscillate at its fundamental resonance frequency.[235] The alternation of two parameters 
measured by QCM-D, resonance frequency (Δf) and dissipation (ΔD), reflected the adsorbed 
mass and the viscoelastic properties of surface-bound materials.[236] The amount of adsorbed 
material for a thin, nondissipative layer can be calculated using the Sauerbrey equation.[237] 
However, the linear relationship between the adsorbed mass and Δf is invalid for hydrated 
layers characterized by high dissipation shifts. For such films, in order to calculate the 
adsorbed mass and viscoelastic properties, theoretical viscoelasticity modeling is 
necessary.[238] In the viscoelasticity model, the dissipation factor reveals the viscous losses 
induced by the deposited mass and carries information on the viscoelasticity of the adsorbed 
layer, reflecting the conformation and binding strength of the adsorbed layer.[239, 240] 
          Nowadays, QCM-D is widely applied into the measurement of physical and biological 
responses of proteins, nucleic acids, enzymes or cells, including signal transduction, antibody 
characterization and protein conformational changes.[241] In the estrogen biology, Su et al 
provided additional evidences of ER-α conformational changes after binding to an estrogen 
receptor element (ERE)-immobilized QCM-D crystal sensor.[242] In their subsequent study, 
they plotted of ER-α adsorption using ΔD as a function of Δf , that reflected the dissipation 
changes depending on surface mass. It suggested that changes of formation occurred from a 
water-rich and a less structured protein layer in the case of non ERE-immobilized surface to a 
dehydrated and tightly-bound protein layer in the case of ERE-immobilized sensor surface.
[243]
 
1.4.3 Photolithgraphy 
         Micro/nanotechnologies engaged in the fabrication of biomaterials are classified as 
bottom-up or top-down approaches.[244, 245] A bottom-up approach consists in synthesizing the 
material from small species via physical interactions or chemical reactions. A top-down 
approach consists in starting with a bulk material and breaking it into smaller pieces using 
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mechanical, chemical, or other form of energy.[246] Photolithography is a highly accurate and 
reproducible top-down fabrication method to design micropatterning biosensors with wide 
ranges of sizes (from 10nm to 100ȝm).[247] In recent studies, photolithography is capable of 
coupling with molecular self-assembly bottom-up approach and fabricating unique functional 
micropatterning substrates for biological applications.[248] The patterning process by 
photolithography generally contains five stages: spin coating, baking, irradiation, developing, 
and lift-off. Briefly, a selective substrate is firstly coated with a thin layer (metal or 
biologically active molecules, such as aluminum, titanium, peptides, proteins, polymers, and 
etc.). After baking and spin-coating a photo-resist material layers, the substrate undergoes 
photo-irradiation. Then, a metal patterned thin layer is formed in an organic solvent (e.g., 
acetone)  and finally processed post-modification with biologically active molecules.[249]  
         The applications of micropatterning technology range from drug screening to diagnosis 
of diseases.[250, 251] In the realm of drug screening, development of micropatterning technique 
can provide cost- and time-saving alternatives for in vivo animal experiments, and further to 
understand drug mechanisms on the single cell or gene hierarchy by fixing the cells in a 
sensitive site.[252] It greatly enhances the efficiency of high-throughput drug screening and 
reduces the drug development cycle. As a rapid and sensitive method, micropatterning based 
biosensors can be used to simplify the process of diseases diagnosis in early phase by 
integrating a variety of biological receptors.[253] In terms of tissue engineering applications, the 
morphology and elasticity of the micro-patterning surfaces is controllable, and hence to 
determine the fate of stem cells, such as attachment, growth, differentiation, and migration.[254] 
Furthermore, use of micro-patterning technique can construct biochips that sizes are in 
identical of single cells, which stimulates tissue regeneration and repair through mimicking a 
unique physiological environment.[255]  
1.5 Project hypothesis, thesis rationale and research objectives 
1.5.1 Project hypothesis 
The research described in this thesis involves the preparation of surface-tethered E2 
biomaterials by bottom-up and top-down approaches in order to systematically investigate the 
 22 
 
potential applications of E2 in cardiovascular regenerative medicine and to understand the 
detailed biological mechanisms. 
For the bottom-up approach, a hypothesis that CH-PC is an available polymer for the 
E2 tethering will be validated as shown in the Figure 1.4. We also set a premise that CH-PC-
E2 conjugates can be self-assembled to functional films undergoing air-drying and rehydration 
process. Finally, CH-PC-E2 functional films recognize estrogen receptors in the cell 
membrane and stimulate cardiovascular protective molecule NO production that are beneficial 
to the cardiovascular system.  
 
Figure 1.4 Tethering E2 to CH-PC polymers for the formulation of self-assembled thin films 
by bottom-up approach.   
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In order to further elucidate the biological mechanisms of surface-tethered E2, we 
assume that surface-tethered E2 could exert biological responses through its non-genomic 
action. This hypothesis will be confirmed through an investigation of tethering E2 to 
micropatterned substrates prepared by photolithography as shown in the Figure 1.5. Then, the 
influence to the phosphorylation level of ERK, which is a significant marker of non-genomic 
signal pathways, will be determined by E2-tethered micropatterned substrates. Finally, the 
genomic action of micropatterned surface-tethered E2 will also be assessed by cancer cell 
proliferation studies.  
 
 
Figure 1.5 Tethering E2 to photolithography-fabricated micropatterned subsrates by top-down 
approach in order to specifically understand E2 non-genomic action. 
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1.5.2 Thesis rationale  
In the first part of the thesis, E2 will be covalently grafted onto chitosan 
phosphorylcholine (CH-PC) polymer backbone as a prodrug strategy. This CH-PC-E2 
conjugate will be used for the fabrication of functional self-assembled film via a bottom-up 
approach. There are several advantages for grafting PC and E2 moiety to chitosan: 1) The 
solubility of chitosan is remarkably increased after PC conjugation; 2) The biocompatibility of 
chitosan is greatly enhanced due to the anti-fouling properties of the PC group. The relevant 
physical characteristics and cellular studies in CH-PC films will be presented in a separated 
chapter; 3) The conjugation of E2 to a CH-PC backbone might increase the stability of E2 and 
preferentially interact with cell or tissue more efficiently in comparison with using the E2 
alone.
[256]
 Due to the co-existence of PC and E2 groups, the properties of CH-PC-E2 conjugate 
in solutions will be investigated by dynamic light scattering (DLS) and zeta-potential 
measurement in order to understand the inter- or intra-molecule interactions. Moreover, the 
physical and mechanical properties of CH-PC-E2 films will be characterized by different 
techniques, e.g. AFM and QCM-D. Finally, the cardiovascular beneficial effect of CH-PC-E2 
film will be explored by determining its effect on nitric oxide (NO) stimulation, which is a 
widely accepted protective signal molecule in the cardiovascular system. These studies above 
will provide a new perspective on the potential biomedical applications of CH-PC-E2 
conjugates, such as novel coating materials in the cardiovascular devices. In the second part of 
the thesis, the purpose is to establish an in vitro model for non-genomic effect studies via 
construction of E2-functionalized micropatterned substrates. To start with, a PEGylated 
surface will be used for the activated E2 ligand immobilization since PEG can preclude non-
specific interactions of irrelevant molecules and enhance the flexibility of E2 specific 
interactions to the cell surface. Moreover, a cell adhesive ligand will be co-immobilized with 
the activated E2 ligand for ensuring the cell attachment. In attempting to achieve these goals, 
micropatterned substrates will be used and fabricated by aligning gold circular regions onto 
the glass substrate via a photolithograph, while exposing them to UV radiations in the 
presence of a photomask.
[257, 258]
 The micropatterned substrates developed by this top-down 
approach, which are identical in size to the site of cells, can be used for controlling the cell 
microenvironment. Moreover, the relationship between the amounts of surface-immobilized 
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E2 and its corresponding biological activity should be evaluated due to the small molecule 
weight of E2 (M.W. ~400). By combining SPR and QCM-D techniques, the quantitative 
information concerning the results of E2 modification on the gold region will be obtained. 
Further, the biological activity of surface-immobilized E2 will be determined via interactions 
to estrogen receptors in situ. After investigating the relevant physical and chemical properties 
of the E2-functionalized micropatterned substrate, a selected non-genomic effect signaling 
pathway will be validated. A challenge here is that the presence of ER in the cell membrane 
has not been confirmed with certainty, although numerous in vitro measurements argue in 
favor of this assumption. In the present study, ERK activity activated by E2-functionalized 
micropatterned substrate will be evaluated by a cell ELISA method, which is an exclusive 
technique that allows measuring the ERK activity quantitatively in situ. Furthermore, the cell 
proliferation study will be performed to determine the influence of E2-functionalized 
micropatterned substrate to E2 genomic effect. Taken these results together, E2-functionalized 
micropatterned substrates may act as biosensors to study the E2 non-genomic properties and 
possibly contribute to clarifying several issues in steroid biology.  
1.5.3 Research objectives 
1) To prepare and characterize CH-PC-based films with different PC substituted ratios as 
well as to study their biological properties in vitro;  
2) To prepare and characterize CH-PC-E2 conjugates as well as to further investigate the 
potential roles of CH-PC-E2 conjugates in the cardiovascular regenerative medicine; 
3) To understand the E2 non-genomic or genomic behavior and study relevant cell signal 
pathways by E2-functionalized micropatterned substrates. 
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Summary of transition 
            In order to develop a self-assembly bottom-up approach for the E2 surface 
immobilization, we selected a chitosan phosphorylcholine (CH-PC) biopolymer as a backbone 
due to its cationic nature and good biocompatibility. In this chapter, the physical and 
biological properties of CH-PC thin films were extensively investigated by the combination of 
SPR, QCM-D, and cellular studies. Combined with SPR and QCM-D measurements, it 
demonstrated that the non-fouling properties of CH-PC films were highly dependent on the 
incorporated PC contents. Moreover, the facts that endothelial cells (HUVEC) form 3D 
spheroid strucutures on the higher level of PC contents of CH-PC films indicated the 
potentials of CH-PC platforms in the cardiovascular regenerative medicine. However, the 
relevant in vivo studies were not performed. In future, 3D spheroid of HUVEC cultured on the 
CH-PC films should be developed and transplanted into myocardial ischaemia animal models 
to investigate their cardiovascular protective efficacy by survival rate or histological analysis. 
The present study provided detailed information for the next chapter of the preparation CH-
PC-E2 conjugates from a polymer perspective. 
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2.1 Abstract 
This study describes the elaboration and characterization of chitosan-
phosphorylcholine (CH-PC) films able to support the formation of cell aggregates (spheroids), 
which are important for tissue engineering and pharmacological studies. The surface 
topography, charge, thickness, and rheology of CH-PC thin films of different levels of PC 
incorporation were characterized by AFM, zeta-potential measurements, SPR spectroscopy, 
and QCM-D measurements. The combined studies indicate that CH-PC films are highly 
hydrated gels, independently of the level of PC incorporation (15 to 40 mol% PC/glucosamine 
units). However, QCM-D studies also established that the amount of fibrinogen adsorbed on 
CH-PC films decreased significantly with increasing PC content. On the macroscopic scale, 
the CH-PC surfaces underwent a transition from moderately cell-adhesive (CH-PC15) to non-
adhesive (CH-PC40). Optical micrographs of HUVEC and MCF-7 cell lines cultured on CH-
PC surfaces showed that they form spheroids on CH-PC25 and CH-PC40 films. 
 
2.2 Author Keywords 
Chitosan; Biopolymers; Polyelectroylte; Adsorption; Thin films 
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2.3 Introduction 
The implementation of nanotechnology and nanoarchitectonics[1] in the design of 
biomaterials has had a major impact on contemporary medicine, particularly in the case of 
medical implants and drug delivery systems. Nanofunctionalized biomaterials play also a 
crucial role as in vitro models to study complex biological phenomena, including cell motion, 
proliferation, and adhesion.[2-6] Current research thrusts are directed towards the design of 
nanostructured surfaces able to reproduced in vitro the three dimensional environment 
experienced by cells. Such smart substrates could provide reliable and cost-effective assays in 
the study of the clinical outcome of new therapies, in addition to, or in lieu of, animal studies. 
A particularly promising approach consists in carrying in vitro assays on three-dimensional 
cell aggregates, or spheroids, rather than on flat cellular monolayers. Such methods are highly 
relevant to oncological conditions, such as tumor invasion and metastasis.[7, 8] There are also 
relevant in studies of the cardiovascular system, where spheroids of endothelial cells (ECs) are 
excellent tools to study the differentiation and functions of endothelial ECs, whereas ECs 
cultured on standard 2-dimensional surfaces lose many of their differentiated phenotypic 
properties.[9] Currently, cell biologists dispose of only a few substrates known to promote cell 
aggregation. Several methods have evolved that promote the formation of cell–cell junctions 
and the creation of cell aggregates. Current methods used to produce spheroids include the 
culture of cells in non-adhesive tissue culture plates placed on an orbital shaker, [10, 11] the 
hanging-drop method which induces the re-aggregation of islets into relatively uniform 
spherical clusters,[12, 13] and the hydrogel micro-well cell-culture method.[14, 15] For in-vivo 
implantations studies, it is preferable to assemble spheroids directly on the biomaterials to be 
implanted. This method allows one to modulate cell/substrate interactions via the adhesive 
properties of the substrate. Chitosan[16, 17] and hyaluronic acid membranes,[18] for instance, 
were used to prepare non-adhesive surfaces. However, in all cases reported so far, cell 
aggregation on a given material was cell line dependent. The availability of simple substrates 
able to induce spheroid formation in a predictable way would certainly stimulate research in 
this field, ultimately widening the range of spheroid-based assays. Cells spontaneously diffuse 
and meet to form compact clusters when they are placed on non-adhesive substrates where 
spreading is energetically unfavorable. In this situation, cells are considered to be in a partial 
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wetting regime in which the cell substrate adhesion energy is less than the cell-cell adhesion 
energy. [19] Therefore, one simple approach to build a library of substrates prone to induce cell 
aggregation consists in preparing thin films using biopolymers consisting of a cell-adherent 
backbone carrying various amounts of cell repelling functions exposed to the film/cell medium 
interface. This palette of substrates could then be used to select the optimal substrate for a 
given cell line.  
Chitosan (CH), a polysaccharide derived from natural chitin, is a ubiquitous 
component of biomaterials in important medical fields, particularly as a substrate in tissue 
engineering and drug delivery.[20] Chitosan is biodegradable, biocompatible, and has 
antibacterial properties. It interacts with components of the extracellular matrix and has 
adhesive properties towards most cell types. Chemically, it is a linear polycation composed of 
β-D-glucosamine and β-D-N-acetylglucosamine residues linked through (1 → 4) linkages. 
Chitosan dissolves readily in acidic aqueous solutions, but it is insoluble in neutral water.[21] 
We reported several years ago, the synthesis of chitosans bearing phosphorylcholine (PC) 
groups (CH-PC, Figure 2.1), designed to be soluble in water over a wide pH range by virtue of 
the hydrophilicity of the PC groups. 
 
 
 
Figure 2.1 Chemical structure of phosphorylcholine-chitosans 
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We demonstrated that CH-PC samples are readily soluble under physiological 
conditions when the level of PC incorporation equals or exceeds ca. 15-20 mol% PC per 
glucosamine unit.
[22]
 Similarly to chitosan, CH-PCs are nontoxic and biodegradable.
[22, 23]
 In 
view of their high solubility in neutral water, CH-PCs were used to prepare estradiol-
prodrugs.
[24]
 However, CH-PCs were never tested as substrates for spheroid growth. 
Remembering that the zwitterionic PC functional group is known to reduce nonspecific 
adsorption to the solid/liquid interface,
[25]
 it would appear that the CH-PC architecture is 
ideally suited to promote and modulate cell aggregation. The study reported here was carried 
out to test this hypothesis.  
Precisely-designed CH-PC samples of identical molar mass and different levels of PC 
incorporation, synthesized under homogeneous conditions,
[22]
 were cast on substrates to form 
thin films. The films were subjected to atomic force microscopy (AFM) examination, zeta-
potential measurements, surface plasmon resonance (SPR) spectroscopy, and quartz crystal 
microbalance with dissipation (QCM-D) measurements in order to determine important 
mechanical cues, such as surface topography, roughness, charge, and rheology, known to 
influence the adhesion of cells on a substrate.
[26-28]
 Human umbilical vein endothelial cells 
(HUVEC) selected as model endothelial cells and MCF-7 human breast cancer cells were 
cultured on CH-PC surfaces of varying PC content and monitored by optical microscopy over 
a period of 4 days. These preliminary in vitro studies indicate that both cell types form 
spheroids on CH-PC substrates and that, on a given substrate, the rate of aggregation depends 
markedly on cell type. The origin of this discrimination among the CH-PC surfaces is 
discussed in light of the physico-chemical properties of the films and their non-fouling 
properties assessed via QCM-D determination of the amount of fibrinogen adsorbed on their 
surface. The dynamics of HUVEC aggregation on CH-PC substrates were evaluated within the 
context of the Douezan and Brochard-Wyart model, based on the random diffusion of cells on 
non-adhesive substrates. 
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2.4  Experimental Section 
2.4.1 Materials 
Water (18.2 MΩ·cm) was deionized using a Milli-Q water purification system 
(Millipore). Sodium cyanoborate, sodium 3-mercapto-1-propane sulfonate (MPS), and 
fibrinogen from human plasma were purchased from Sigma-Aldrich Co. All solvents were of 
reagent grade and used as received. Spectra/Pore membranes (Spectrum) were employed for 
dialysis. Chitosan (CH) (Mw 50~100 kDa, DDA: 88%) was purchased from Fisher Scientific 
Inc. It was deacetylated to a DDA of 98%, following a known procedure.[22] 
Phosphorylcholine glyceraldehyde was prepared as described previously.[29]  
2.4.2 Synthesis and characterization of phosphorylcholine-chitosans (CH-
PC) 
The CH-PC samples were obtained by reaction of deacetylated CH with various 
amounts of phosphorylcholine-glyceraldehyde (PC-CHO) (Figure 2.1) following a 
modification of the procedure described in Tiera et al.,[22] which is described for the synthesis 
of CH-PC25. A solution of PC-CHO (0.38 g, 1.56 mmol) in water (10 mL) was added 
dropwise to a solution of deacetylated chitosan (0.52 g, 3.2 mmol of monosaccharide residue) 
in aqueous acetic acid (20 mL, 2 wt%) kept at 0 oC. At the end of the addition, the solution 
was stirred for 30 min at 0 oC. The pH of the reaction mixture was adjusted to 6.5 by adding 
aqueous NaOH (1.0 M). The reaction mixture was stirred for 1 h at room temperature. It was 
cooled to 0 oC, and a solution of sodium cyanoborohydride (0.48 g, 7.61 mmol) in water (10 
mL) was added dropwise under stirring. Thereafter, the reaction mixture was warmed to room 
temperature and stirred for 20 h. It was dialyzed (membrane of MWCO 12,000-14,000 Da) 
first against water for 2 days, then against aqueous NaOH (0.05 M) for 1 day, and finally 
against water for 2 days. The polymer CH-PC25 was isolated by lyophilization (yield: 72%). 
The degree of PC substitution was calculated from the 1H NMR spectrum of CH-PC solutions 
(10 mg mL-1) in D2O/DCl (100/1, v/v) recorded at 70 oC (see Figure SI.2.1) and by a 
colorimetric assay for phosphorus.[29, 30] The two methods yielded identical values, within 
experimental uncertainty. 
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2.4.3 Preparation of CH-PC solutions 
Solutions of CH-PC in 0.08 N HCl (pH ~ 3, 2.0 g L
-1
) were prepared and kept 
overnight at room temperature. Subsequently, they were filtered through a 0.45 ȝm filter. 
Their pH was adjusted to 6.8 by addition of a few drops of aqueous NaOH (10%). The 
resulting solutions were diluted to a concentration of 1.0 g L
- 1 
with a 10 mM phosphate buffer 
(pH=7.4). The resulting solutions were kept overnight at ambient temperature and filtered 
through a 0.45 ȝm filter prior to use. 
2.4.4 Dynamic light scattering (DLS) and zeta potential measurements of 
CH-PC solutions. 
DLS experiments were performed on a CGS-3 goniometer (ALV GmbH) equipped 
with an ALV/LSE-5003 digital correlator (ALV GmbH), a He–Ne laser ( = 632 nm) and a 
C25P circulating water bath (Thermo Haake). The scattering angle was set at 90
o
. A cumulant 
analysis was applied to obtain the diffusion coefficient of the scattering objects in solution. 
The hydrodynamic radii (Rh) of the nanoparticles were calculated from the diffusion 
coefficients using the Einstein-Smoluchowski equation. The zeta potential (-potential) of 
polymers in solution was determined with a Delsa Nano C instrument (Beckman Coulter, 
USA) equipped with a flow cell. Both DLS and -potential measurements were performed at 
25
o
C with polymer solutions (1.0 g L
-1
) in a 10 mM phosphate buffer pH 6.8. 
2.4.5 Dynamic AFM measurements 
AFM imaging was performed in the tapping mode™ at ambient temperature with a 
MultiMode scanning probe microscope and NanoScope 5 controller (Bruker). Images were 
acquired with samples immersed in phosphate buffer (pH 6.8). Surfaces were analyzed using 
sharp silicon nitride levers (model SNL-10, Bruker) with a radius of curvature of 6 nm, a 
nominal spring constant of 0.24 N m-1, and a resonance frequency of 32 kHz in liquid. The 
scan rate and image resolution were 1 Hz and 512  512 pixels, respectively. Images were 
corrected for bow/tilt by a third-order plane fit correction. Glass slides coated with 2 nm Ti 
and 20 nm Au were used as substrates. They were cleaned with a piranha solution containing 
concentrated sulfuric acid and 35 vol% hydrogen peroxide (v/v 7/3) (WARNING: Piranha 
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solution is extremely reactive and should be handled with extreme caution.) and rinsed with 
deionized water and ethanol before use. CH-PC films were prepared by immersing the slides 
in a CH-PC solution (1.0 g L- 1) for 4 h. The slides were rinsed with a phosphate buffer 
solution and transferred to an AFM liquid cell filled with the same buffer. 
2.4.6 Zeta potential measurements of CH-PC films 
The zeta potential of the CH-PC films was measured with a Delsa Nano C instrument 
(Beckman Coulter, USA) equipped with a flat surface cell. Rectangular glass supports (30 x 
10 mm) cleaned with a piranha solution and rinsed with water and ethanol prior to use were 
kept in a CH-PC solution (1.0 g L-1) for 4 h. Subsequently, they were placed in a sample cell 
filled with a suspension of particles (polystyrene) in 10 mM NaCl at a pH 6.8 kept at 25 °C. 
The electrophoretic movement of the particles under the applied electric field was detected 
along the vertical direction toward the center of the sample cell using the Doppler shift of 
scattered light 
2.4.7 Surface plasmon resonance (SPR) measurements 
SPR measurements were carried out with a SR7000 instrument (Reichert Inc.)
 
equipped with a flow cell (1 µL, surface area: 12 mm
2
), an injector port, a six-way low-
pressure solvent selection valve, and a syringe pump (model PHD 2000, Harvard Apparatus) 
described previously.
[31] 
Surface plasmons were excited at the metal/solution interface in the 
Kretschmann configuration using the p-polarized output from a GaAlAs laser (15 mW, 780 
nm) and a hemicylindrical sapphire prism. The prism stayed in optical contact (Cargille 
immersion oil Type A liquid, n = 1.515) with the underside of a gold-coated glass slide. Light 
totally internally reflected from the gold/solution interface was detected with a 3696-pixel 
CCD linear array for which the optical pixel signals were digitized with a 14-bit analogue-to-
digital converter. In the angle tracking mode the SPR minimum pixel, which corresponds to 
the minimum SPR angle (m), was tracked with time by a centroid algorithm using the signal 
from a few pixels on either side of the pixel of lowest intensity. Reflected light intensity 
versus pixel number curves (referred to as array scans) were generated as well. The shifts in 
the minimum pixel were converted to resonance angle changes (m) using the pixel-to-
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incident angle relation, i.e., 1 pixel = 0.00506°, established through calibration of the SR7000 
instrument across the refractive index range of 1.33-1.38 with pure water and aqueous 
solutions of 4-50 wt% ethylene glycol, as described in details in Badia et al.
[31]
 Shifts in m 
calculated from angle tracking agreed well with those obtained from array scans. The Fresnel 
model was used to calculate the “dry” film surface coverage (d from the shift in m (see 
ESI). D263 glass slides (12.5 mm × 12.5 mm × 0.9 mm) coated with 1 nm Cr and 45 nm Au 
(Reichert Inc.) were cleaned with a piranha solution and rinsed with deionized water and 
ethanol before use. They were submerged in a MPS solution in ethanol (1 mM) for at least 16 
h. The substrates were rinsed copiously with ethanol to remove excess MPS and dried with 
nitrogen, and placed in the sample cell. Phosphate buffer was passed through the cell (50 µL 
min
−1
) to establish the baseline. Next, a polymer solution was injected manually into the 
sample loop and carried into the measurement chamber by a constant flow of buffer until the 
shift in SPR minimum position was constant (ca. 30 min.). The cell was then rinsed with the 
buffer.  
2.4.8 Quartz crystal microbalance with dissipation (QCM-D) 
measurements 
QCM-D measurements were carried out with a QCM-D model E4 system (Biolin) that 
allows for simultaneous measurements of frequency changes (Δf) and energy dissipation 
changes (ΔD).[32, 33] QCM-D signals were registered for the fundamental frequency (5 MHz) 
and m = 5 overtones (15, 25,…, 55 MHz). For clarity, the results are presented as the 
normalized frequency and dissipation shifts registered for the fifth overtone (25 MHz). The 
layer thickness and the film mechanical properties were calculated based on the Voigt 
viscoelastic model.
[31]
 The surface coverage (or “wet” mass) w was calculated based on Δf 
and ΔD for five overtones. The film density was obtained by combining QCM-D and SPR data 
(equation (SI 3)-(SI 4)). This density value was used in final modeling procedure to calculate 
the film thickness d, and storage and loss moduli (G’ and G”, respectively). In the model it 
was assumed that G’ and G” are characterized by a power-law frequency dependence with 
critical exponents α and β, respectively (G’ ∝ fα and G”∝ fβ). 
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Cleaned gold-coated 5-MHz AT-cut quartz crystals (Quartz Pro) were submerged in a 
MPS solution in ethanol (1 mM) for at least 16 h. They were rinsed copiously with ethanol to 
remove excess MPS, dried with nitrogen and placed in the sample compartment. A solution of 
CH-PC in a phosphate buffer was introduced into the sample cell at a flow rate of 20 µL min
-1
 
until the frequency and dissipation reached constant values. Next, the cell was flushed with 
buffer to remove excess polymer. For studies of fibrinogen adsorption on CH-PC, a solution of 
fibrinogen (0.1 g L
-1
) was introduced into the cell at a rate of 20 µL min
-1
. Free fibrinogen was 
removed subsequently by rinsing the chamber with phosphate buffer. All the experiments 
were performed at 20.00 ± 0.05 
o
C. 
2.4.9  Ellipsometry measurements 
Ellipsometry measurements were carried out on an M-2000V multi-wavelength 
ellipsometer (J.A. Woollam Co.) at an incident angle of 75o with a wavelength range of 370 to 
1000 nm. Data were analyzed with the WVASE32 software, supplied by the manufacturer. 
The film thickness was estimated using the relation of Cauchy (equation 1): �ሺ�ሻ = �௡ + ஻��2 + ஼��4                  (1) 
where Ȝ is the wavelength and n is the refractive index. The refractive index value was taken 
as 1.59, based on previous publications.[34]  
CH-PCx films were prepared on silicon wafers cleaned with a piranha solution 
(Caution, see above), washed with deionized water and dried. A few drops of a CH-PC 
solution (1.0 g L–1) in a 10 mM phosphate buffer of pH 6.8 were placed on a cleaned wafer 
which was then air-dried in a hood for 17 hrs. The film was rinsed with water and dried prior 
to measurements. 
2.4.10 Cell culture 
Polymer-coated substrates were prepared by drop-casting CH-PC solutions in 
phosphate buffer pH 6.8 (1.0 g L
-1
) in 96-well plates (50 L per well), followed by water 
evaporation at ambient conditions in a fume hood. Human umbilical vein endothelial cells 
(HUVECs) (purchased from Lonza) were grown within three passages in endothelial growth 
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medium-2 (EGM-2; Lonza) supplemented with 10% fetal bovine serum. The cultures were 
maintained in an atmosphere of humidified 95% air and 5% CO2 at 37 °C. HUVECs were 
harvested using 0.25% trypsin-EDTA and seeded on CH-PC films at a density of 50,000 cells 
per well. MCF-7 human breast cancer cells (HTB-22
TM
), purchased from the American Type 
Culture Collection, were cultured in Eagle’s Minimum Essential Medium (MEM, Sigma), 
supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine (Wako), 1 mM sodium 
pyruvate (Wako), 1% non-essential amino acids (Gibco) and 1% penicillin-streptomycin 
solution (Wako) in a humidified 5% CO2 atmosphere at 37
o
C. Cells were harvested by using 
10,000 cells per well. Immediately prior to cell seeding, the CH-PCx films coated well plates 
were sterilized with 75% ethanol, washed three times with phosphate buffer, and conditioned 
for 5 min in the EGM-2 culture medium (HUVEC) or MEM supplemented with 10% FBS 
(MCF-7). 
2.4.11 Cell observation by optical microscopy 
Observations of cells were conducted over a period of 4 days after seeding using a 
motorized inverted IX81 microscope (Olympus) equipped with a charge-coupled device 
camera (Retiga-EXi, Q-Imaging), a motorized stage (Molecular Devices), and controlled by 
the MetaMorph Imaging System (ver. 7.6.3.0, Molecular Devices). 
2.5  Results and discussion 
2.5.1 Morphology and charge of the CH-PC Films 
The nanoscale topography of the substrates, known to affect cell adhesion, was 
assessed by atomic force microscopy (AFM), an effective tool for studying the morphology of 
nanostructured surfaces in real-space and under realistic conditions. CH-PC films cast on 
hydrophilic glass and immersed in a pH 6.8 phosphate buffer were observed by AFM. 
Selected images and cross-sectional profiles taken along the X-axis are presented in Figure 2.2 
for films obtained with the three CH-PC samples. All films present surface features that 
increase in size from small islets to larger globular structures with increasing levels of PC 
groups on the polymer. Islets ~ 1.5 nm in height and ~ 13 to 22 nm in width form 
predominantly in the case of CH-PC15. More pronounced features can be seen on the surfaces 
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of CH-PC25 and CH-PC40 films. Globular protrusions ~ 3 nm in height and ~ 40 to 56 nm in 
width are observed on the surface of CH-PC25 films. In the case of CH-PC40 films, the 
protrusions are larger (~ 4 nm in height and ~ 53 to 71 nm in width).  
 
Figure 2.2 (a) AFM topography images of CH-PC films (2 m  2 m) acquired in a 
phosphate buffer pH 6.8; maximum height (Z-range): 12 nm (CH-PC15 and CH-PC25) and 25 
nm (CH-PC40) and cross-sectional profiles along the X axis corresponding to the yellow lines 
drawn through the AFM images; (b) Height and width of the surface features determined by 
AFM. 
Intrigued by the distinctively different features of the film surfaces depending on the 
polymer structure, we examined CH-PC solutions by dynamic light scattering (DLS) 
measurements. Although the solutions were clear to the eye, DLS revealed the existence in 
solution of loosely self-assembled CH-PC assemblies of broad size distribution, with 
hydrodynamic radii (Rh) on the order of ~ 100 nm. The Rh values exhibited a slight 
dependence on the PC-incorporation level. The polymer with the fewest PC substituents (CH-
PC15) forms significantly larger objects (Rh = 117 ± 5 nm), compared to the more substituted 
chitosans (Rh = 84 ± 4 nm and 96 ± 5 nm, for CH-PC25 and CH-PC40, respectively), pointing 
to the prevalent role of ion-pairing among PC groups in controlling the solution properties of 
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CH-PC samples.[24] For all polymers, the particles exhibited a positive zeta-potential (22 ± 3 
mV), independently of their PC-substitution levels. The islets observed by AFM are much 
smaller than the size of the nanoparticles detected by DLS in solutions of this polymer, 
particularly in the case of CH-PC15, which indicates that loosely bound nanoparticles formed 
in solution reorganize upon adsorption on the negatively charged MPS surface. 
Surface topography has a direct influence on cell affinity towards the underlying 
substrate. Cell adhesion and spreading can be significantly inhibited by the nanoscale features 
(ca. 100 nm) that approximately match the length scale of integrin clustering in focal adhesion. 
[35, 36]
 Focal contact formation is disrupted to a lesser degree in the case of very large (e.g. a 
few micrometers) or very small (< 50 nm) surface features. For films of CH-PC15, the width 
of the surface features (ca. 18 nm) could inhibit cellular adhesion somewhat, but they may be 
too small to induce cellular aggregation. In the case of CH-PC25 and CH-PC40 films, the 
width of the surface features becomes significantly larger (ca. 40 to 70 nm). They are within 
the range of distances required for integrin clustering, which may favor the formation of 
spheroids. 
Films of the three polymers coated on hydrophilic glass were positively charged. The 
ζ-potential of CH-PC15 films (+ 21.0 ± 2.0 mV) was similar to the ζ-potential of the nano-
assemblies formed by this polymer in buffer (+ 23.7 ± 2.1 mV). The ζ-potentials of CH-
PC25 and CH-PC40 films (+ 16.3 ± 1.7 mV and + 13.2 ± 1.2 mV, respectively) were lower 
than the values recorded for the respective nanostructures in solution, adding further evidence 
of partial disruption of the CH-PC25 and CH-PC40 particles upon adsorption on the glass 
substrate and concomitant migration of PC groups from the aggregate interior towards the 
water/film interface. [24] The amount of interfacial charges influences cellular behavior 
significantly, mainly by controlling protein adsorption at the surface.[37] Cell attachment to 
substrates is usually mediated by adhesion proteins contained in serum-supplemented culture 
medium in vitro or blood in vivo. The ability of the substrates to adsorb such proteins from 
serum determines their ability to support cell adhesion. As a general rule, cell affinity towards 
a surface increases with increasing charge density of the substrate. The more a surface is 
charged, the more it is coated with proteins from cell medium or blood, and it is through this 
adsorbed protein layer that cells sense the surface and adsorb as well. Therefore, the low zeta 
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potential values observed for the films of high PC content, i.e. CHPC-25 and CH-PC40, are 
favorable factors for reducing cell-substrate affinity and hence enhancing cell aggregation. 
2.5.2 Hydration and mechanical properties of CH-PC films 
In addition to surface charge and topography, cellular aggregation can be significantly 
influenced by the mechanical properties of the underlying films and by their hydration level. 
The aim of combined surface plasmon resonance (SPR) and quartz crystal microbalance with 
dissipation (QCM-D) experiments presented below was to determine how these 
physicochemical parameters are affected by the amount of PC groups in the films. For these 
experiments the polymers were deposited on gold substrates coated with MPS used to form a 
negatively charged interface analogous to the substrates used for AFM imaging and -
potential measurements. Changes of the SPR resonance angle, ΔΘ, and the QCM-D frequency, 
F, were recorded as a function of time following injection of a CH-PC solution in the sample 
cell of the SPR and QCM-D systems fitted with MPS-coated gold. The corresponding SPR 
and QCM-D traces are presented in Figure 2.3.  
 
Figure 2.3 SPR and QCM responses of MPS-modified gold substrates when exposed to 
solutions of CH-PC (1.0 g L- 1) in phosphate buffer, pH 6.8: a) changes in the SPR resonance 
angle (m) and b) changes in resonance frequency (f5/5, top) and dissipation (D5, bottom) 
observed in the QCM-D experiments for the 5th overtone.  
Immediately upon injection of polymer solutions, the resonance angle Θ and the 
frequency F underwent rapid changes. The resonance angle increased, while the frequency 
decreased, implying that the polymers adsorb on the substrates. This process was accompanied 
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by an increase in the dissipation, D, measured in the QCM-D experiments (Figure 2.3b, lower 
panel). When Θ, F, and D reached constant values, the flow of the polymer solution was 
discontinued. It was replaced by a flow of buffer, which caused a slight decrease of the SPR 
resonance angle and weak changes of the QCM frequency and dissipation signals. Hence, a 
small amount of excess polymer was removed by the flow of buffer. The SPR and QCM-D 
signal change due to polymer adsorption was calculated by comparing the signals in polymer 
free buffer. The values of the shifts Θm, f5/5, and D5 recorded by SPR and QCM-D at the 
end of the adsorption/rinse sequence for the three CH-PC samples are listed in Table 2.1 
together with values recorded for chitosan used as a control sample (see SI for details on the 
chitosan adsorption protocol). From the changes of the SPR and QCM-D signals, it is possible 
to evaluate the amount of adsorbed polymer. The “dry” polymer mass, d, which corresponds 
to the weight of adsorbed polymer without solvent, was calculated from the film thickness 
determined from SPR data using a Fresnel model. The adsorbed “wet” mass, w, defined as 
the sum of the weight of adsorbed polymer and the mass of the water trapped in the film, was 
obtained from the QCM-D data, using the Voigt viscoelastic model. This data treatment, 
which assumes that the experimentally obtained frequency depends on the film storage and 
loss moduli, has proven to be useful to model protein films.[38] It was used also to describe the 
dynamics and composition of films formed by estradiol-conjugated CH-PC samples.[24] 
Details of the calculations and data modeling are provided in SI. The wet and dry mass of 
adsorbed CH-PC films increase with increasing level of PC incorporation. The wet mass of 
each film was one order of magnitude larger than its dry mass (Table 2.1).  
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Table 2.1 Physico-chemical properties of films formed by CH-PC15, CH-PC25, CH-PC40, 
and CH thin films formed on MPS-modified gold surfaces at pH 5.5.a 
Polymer SPR measurments QCM-D measurments Water 
content 
[wt%] 
Density 
[g dm-3] 
Thickness 
[nm] 
G’ 
[MPa] 
G’’ 
[MPa] m 
[] 
d 
[mg m-2] 
f5/5 
[Hz] 
D5 x 
106 
w 
[mg m-2] 
CH-
PC15 
0.04932 0.908 -46.3 5.2 10.1 91% 1038 9.72 0.75 0.34 
CH-
PC25 
0.06128 1.132 -48.1 5.5 11.8 90% 1039 11.3 0.60 0.22 
CH-
PC40 
0.07873 1.467 -55.6 6.9 15.9 92% 1036 15.3 0.62 0.27 
CHb 0.02479 0.420 -13.5 2.9 4.39 90% 1045 3.97 - - 
 
am – SPR resonance angle, d – “dry” mass, f5/5 – QCM-D frequency shift for the 5th overtone, 
D5 – QCM-D dissipation change for the 5th overtone, w – “wet” mass, G’ -storage modulus at 25 
MHz, and G” - loss modulus at 25 MHz. The estimated error in reported values is 5%, except for G’ 
and G” where it equals ca. 10%. b) Experiments were performed with solutions of CH in an acetate 
buffer at pH 5.5, since chitosan is insoluble in water at neutral pH. Due to the low amount of adsorbed 
polymer, it was not possible to estimate the values of the storage and loss moduli. 
 
The water content of the CH-PC films determined from d and w (see details in SI) is 
91 ± 1wt%, a value similar to the water content of chitosan film (90%). PC groups are 
hygroscopic and surrounded by a hydration shell formed by ca. 23 - 24 water molecules per 
PC group
[39]
 held together by weak electrostatic interactions (ionic hydration).
[40]
 One would 
expect that the presence of PC groups linked to CH would increase the film hydration level 
proportionally to the amount of PC moieties. The QCM-SPR data indicate that this not the 
case. This observation may be an indication that the PC groups are preferentially located on 
the film/water interface, where they interact freely with surrounding water molecules, as 
suggested also by the zeta-potential measurements (see above). This result is important, as PC 
groups must be exposed on the film/water interface in order to act as nonfouling groups. The 
migration of PC groups towards the film/water interface has been reported previously.
[41, 42]
 
The thickness (d) of the films, estimated from QCM-D data using 1037 ± 2 g dm
-3
 as the 
average film density (equation (SI 3)) increases from ~ 4 nm for CH films to ~ 15 nm for CH-
PC40 films, comparing to data measured by SPR ~0.4 nm for CH films and ~1.4 nm for CH-
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PC40 films. The difference in film thickness reflects a difference in the chain conformation 
adopted by the polymers in the hydrated films. CH-PC films result from the adsorption on the 
surface of preformed nanoparticles with numerous PC-PC crosslinking points (see DLS results 
above). These connecting points are preserved in the films, preventing the polymers chains 
from adopting an extended conformation.  
The storage and loss moduli of the films ranged from of 0.22 to 0.75 MHz, which are 
typical values of biopolymer-based hydrogels, multilayers, and thin films.[43] The frequency 
dependence of the storage and loss moduli of CH-PC films was approximated by power laws 
with exponents α and β, respectively: Gƍ ∝ fα and GƎ ∝ f β,[43, 44] that led to α and β values 
approximately equal to 1, which are characteristic of gels or solutions of entangled polymers 
probed on short time scales.[44, 45] They support the description of CH-PC films as highly 
hydrated, entangled polymer gels with temporary junctions formed through ion pairing 
between PC groups. Overall, the SPR and QCM-D experiments indicate that the thickness and 
the rheology of hydrated CH-PC films adsorbed on MPS-coated gold exhibit a weak 
dependence on the amount of PC groups bound to the chitosan chains.  
2.5.3 Fibrinogen adsorption on CH-PC films. 
The importance of the adsorption of plasma proteins in controlling cell/surface 
interactions is commonly acknowledged. A model protein, fibrinogen, was chosen in this 
study since it plays an important role in regulating cell adhesion and activation. Fibrinogen is a 
large plasma protein that is negatively charged in physiological conditions (340 kg mol
-1
, pI = 
5.5) and readily adsorbs on most surfaces. CH-PC films were assembled on MPS surfaces in 
the QCM-D sample cell following the protocol described above. After rinsing with PBS 
buffer, a fibrinogen solution (0.1 g L
-1
) in the same buffer was injected in the cell. Changes of 
the frequency and dissipation were monitored as a function of time following fibrinogen 
injection (Figure 2.4). The amount of fibrinogen adsorbed on each film (Figure 2.4, left panel) 
was estimated from the frequency shifts using the Sauerbrey equation (equation (SI 2)). Since 
the CH-PC films on which fibrinogen is adsorbed exhibit some dissipation, the adsorbed 
values obtained by the Sauerbrey equation are mere estimates of the real amount of adsorbed 
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(A) 
fibrinogen. Nonetheless, the values obtained give useful information on the relative non-
fouling characteristics of the three CH-PC surfaces. 
 
 
Figure 2.4 (A) Adsorption of fibrinogen on CH-PC films. Changes in resonance frequency and 
dissipation observed for the 5th overtone (upper and lower panels, respectively) for MPS-
modified gold substrates coated with CH-PC upon exposure to a fibrinogen solution (0.1 g L-1, 
pH 6.8). The arrows indicate the time corresponding to the onset of the films rinse with PBS 
buffer. (B) Amount of fibrinogen adsorbed on the CH-PC coated substrates. 
Films of CH-PC15 retained ~ 0.13 ȝg cm-2 fibrinogen, a value almost one order of 
magnitude lower than the amount of fibrinogen adsorbed on high affinity substrates.
[46]
 For 
CH-PC40 films, the amount of adsorbed fibrinogen was less than 0.01 ȝg cm-2, the detection 
limit of the QCM-D employed. It was slightly above the detection limit in the case of CH-
PC25 films. These results confirm that the PC groups retain their anti-fouling characteristics 
upon covalent attachment to chitosan and indicate that the film resistance against fibrinogen 
adsorption increases with increasing degree of PC substitution on the chitosan chains. The 
significant effect of PC incorporation level on the amount of fibrinogen adsorbed on CH-PC 
surfaces may be attributed to the increase in the surface concentration of PC as a result of the 
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migration of PC groups towards the water/film interface inferred from zeta potential 
measurements and QCM-D data (vide supra). Noting that the size of a fibrinogen molecule 
(length  diameter = ca. 45  10 nm x nm) is of the same order as the size of the features 
observed on the surface of wet CH-PC films by AFM, it is likely that surface topography also 
affects the modality and extent of protein adsorption on CH-PC films. [47, 48] 
2.5.4 Aggregation of human umbilical vein endothelial cells (HUVECs) and 
MCF-7 cells on CH-PC films 
Substrates for cellular assays were prepared by drop casting a CH-PC solution onto 
cell culture dishes. Previous studies revealed that the drop-cast CH-PC films were positively 
charged.
[24]
 Their thickness, determined by ellipsometry, was 6.6 ± 0.1 nm, 10.0 ± 0.1 nm, and 
11.4 ± 0.1 nm, respectively, for CH-PC15, CH-PC25, and CH-PC40. These values are on the 
same order as the thickness of the films prepared in-situ and analyzed by QCM and SPR (see 
above). The cell adhesion properties of CH-PC films were assessed by monitoring as a 
function of cultivation time the aggregation status of HUVECs and MCF-7 cells seeded on the 
various substrates. HUVECs adopted a spherical shape on CH-PC15 films. Within 4 days, 
they formed small clusters that became loosely connected with time (Figure 2.5A and Figure 
2.5E). On CH-PC25 and CH-PC40 films, HUVECs started to form clusters after 2 hrs. The 
clusters grew with time and eventually formed 3D aggregates. The diameter of the aggregates 
ranged from 200 to 400 ȝm after 1 day (Figure 2.5B and Figure 2.5C) and after 4 days they 
reached values exceeding 500 ȝm and 800 ȝm on CH-PC25 and CH-PC40, respectively. The 
size of the aggregates is commensurate with objects, also named spheroids, consisting of a 
large number of cells (Figure 2.5F and Figure 2.5G). Interestingly, tubular extensions formed 
on the rim of the spheroids (arrow in Figure 2.5G). These protrusions are known to contribute 
favorably to the vascularization of cellular grafts.
[49] 
HUVECs cultivated on uncoated 
polystyrene plates used as control adhesive substrates, adopted an elongated shape and 
eventually reached confluence (Figure 2.5D and 2.5H). Identical in vitro assays were carried 
out with MCF-7 cells, commonly used to tumors. Representative micrographs recorded 1-day 
and 4-days of cultivation on the three CH-PC films are presented in Figure SI.2.4 in SI. As in 
the case of HUVECS, MCF-7 cells formed spheroids on CH-PC 40 and CH-PC 25 film. This 
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observation is a strong indication that the propensity of CH-PC films (25 to 40% PC) to 
promote cell aggregation is not cell line dependant, although the kinetics of cell aggregation 
may differ depending on cell type. Our observations differ from results obtained previously S. 
Meng et al. who reported that a CH-PC sample synthesized by an heterogeneous process 
formed substrates adhesive towards HUVECs even though the PC content of the polymer was 
high (~ 0.60 wt% Phosphorus).
[50]
 The CH-PC samples described here were obtained under 
homogeneous conditions that favor random distribution of the PC groups along the CH chain, 
which may affect the adhesive characteristics of thin films formed by the polymers. 
 
Figure 2.5 Optical micrographs of HUVECs on CH-PC coated surfaces 1 day and 4 days after 
seeding (micrographs A to C and E to G, respectively), and on polystyrene tissue culture 
plates (micrographs E and H); Scale bar: 200 ȝm. 
To describe the dynamics of HUVEC aggregation on CH-PC25 and CH-PC40 films, 
we measured the number of clusters per unit area, N(t), at different times. A “cluster” is 
defined as any set of connected cells, including unique cells. S. Douezan and F. Brochard-
Wyart have shown that the number of clusters per unit area in function of the time can be 
modeled by equation (2): �ሺ�ሻ = �0ଵ+��0�                                    (2) 
where N0 is the initial number of cells per unit area and Vcell ~ dcell Vcell (respectively, the cell 
diameter and the average cell velocity) is the rate constant in the collision theory.
[51]
 We fitted 
the experimental data with equation (2) for the different substrates (see Figure SI. 2.5 in ESI). 
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A good agreement with the theoretical model was obtained using K ≈ 5.4× 10-13 m2 s-1. For 
CH-PC25 films and K ≈ 9.6 × 10-13 m2 s-1 for CH-PC40 films. These values yield a cell 
velocity Vcell ~ K / dcell ~ 0.1 μm s-1. The K and Vcell values obtained here are similar to the rate 
constant K ≈ 1.5 × 10-13 m2 s-1 and cell velocity Vcell = 0.07 ȝm-1 determined earlier in the case 
of cells deposited on poly(ethylene glycol)-poly-L-lysine coated substrates known for their 
non-adhesive characteristics.
 [19] 
 
2.6  Conclusions 
Table 2.2 presents an overview of the key features of the three CH-PC films. While the 
thickness of the films increases significantly with PC content, there are only slight differences 
among other physical attributes of the CH-PC substrates, such as water content, surface 
topography, and rheological properties. Nonetheless, differences among substrates are 
recognized by fibrinogen, an important protein involved in cell adhesion. Fibrinogen is 
adsorbed onto CH-PC15 substrates and to a much lesser extent to CH-PC25 substrate. It does 
not adsorb on CH-PC40 films. We attribute this discrimination to an increase of the 
concentration of the antifouling PC group on the film/water interface as the PC degree of 
substitution of chitosan passes from 10 to 40 mol%. Cells readily detect differences among the 
films and respond accordingly in terms of adhesion behavior, yet physico-chemical methods 
applicable in the case of wet films are not sufficiently sensitive to detect significant 
differences between the substrates. High sensitivity analyses performed on dry films, such as 
X-ray photoelectron spectroscopy (XPS), are not reliable herein view of the extensive surface 
reorganization that occurs upon drying CH-PC substrates.
[24]
 This study demonstrates that CH-
PC films form promising platforms for 3D-cellular grafts as well as oncological studies. 
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Table 2.2 Overview of the properties of CH-PC films. 
 
CH-PCx films 
Film properties 
Fibrinogen 
adsorptionb 
[µg cm-2] 
HUVEC 3D 
aggregatesc Thicknessa 
Water 
contenta 
[wt%] 
Zeta 
potential 
[mV] 
 
 
CH-PC15 
9.5 nm ~90 +23.7 
~0.13 No 
 
 
CH-PC25 
11.3 nm ~90 +16.3 
~0.04 Yes 
 
 
CH-PC40 
15.4 nm ~90 +13.2 <0.01 Yes 
 
 
CH-PC backbone 
 
Protonated glucosamine 
 
Phosphorylcholine moiety 
 
a) From QCM and SPR data ; b) from QCM data ; c) optical microscopy observation after 4 days. 
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2.9 Appendix A. Supporting information 
Determination of the PC-substitution level of CH-PC by 
1
H NMR 
spectroscopy  
1H NMR spectra of CH-PC solutions (10 mg/mL) in D2O/DCl (100/1, v/v) were 
recorded at 70 oC on a Bruker ARX-400 400-MHz spectrometer (Figure SI.2.1, Figure SI.2.2 
and Figure SI.2.3). The PC substitution level was determined by two methods: 1) Table from 
the areas (ICH2) of the signal at δ4.λ ppm attributed to the resonance of the methylene group of 
NHCH2CH2OP (signal c, Figure SI.2.1) and of the signals due to the anomeric protons of PC-
substituted and unsubstituted glucosamine residures, H1s and H1, using DS = (1/2) ICH2/ 
IH1+IH1s or from the areas of the signals due to the two types of anomeric protons, H1s and H1 
using DS = IH1s/ IH1+IH1s. 
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Figure SI.2.1 
1H NMR spectrum of CH-PC40, temperature 70 oC, solvent D2O/DCl. 
 
 79 
 
 
Figure SI.2.2 
1H NMR spectrum of CH-PC25, temperature 70 oC, solvent D2O/DCl (1%). 
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Figure SI.2.3 
1H NMR spectrum of CH-PC15, temperature 70 oC, solvent D2O/DCl (1%). 
SPR data modeling 
To apply Fresnel modeling, the real and imaginary components (’ and ”, 
respectively) of the dielectric functions of the surface plasmon-supporting metal layer at the 
wavelength of excitation (780 nm here) must be known. For optically transparent media, ” = 
0 and the dielectric constant ’ is equal to the square of the refractive index, ’ = n2. The 
changes in resonance angle position m were calculated using a six-layer model 
incorporating the sapphire prism (’ = 3.1002),[1] the Cr adhesion layer (’ = -2.0185, ” = 
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37.5755, d = 1 nm),
[2]
 the Au layer (’ = -23.886, ” = 1.7435, d = 45 nm),[3] the polymer film 
(’f and df unknown), and the buffer solution (’s = 1.7814 for phosphate buffer pH 6.8). It is 
generally not possible to determine both ’f and dSPR for an adsorbed, thin organic film from a 
single m value. Any number of different combinations of ’ and dd can produce the same 
shift in resonance angle. Thus, to obtain the film thickness from m, the film index of 
refraction must be known. The value of ’f employed here was 2.1025 (corresponding to nf = 
1.45) for CH-PC films.
[4, 5]
 Modeling was performed by using Winspall software (version 
3.02). Knowing the dry film thickness dd, the surface coverage d (i.e. adsorbed “dry” mass 
per unit area) can be calculated using the relation: Γௗ = �ௗ ௡�−௡�ௗ௡ ௗ௖⁄                                                                                                            (SI 1) 
where ns is the refractive index of buffer and dn/dc is the refractive index increment of 
polymer solution. The values of dn/dc were taken from previous study.
[6]
 The thickness of the 
Au layer was determined using a multiwavelength ellipsometer equipped with a QTH lamp 
and rotating compensator (Model M-2000V, J.A. Woollam Co., Inc.). 
 
QCM-D data modeling. 
The amount of adsorbed material for a thin, nondissipative layer can be calculated 
using the Sauerbrey relationship,
[7]
 where Δf is linearly related to the adsorbed mass, including 
the mass of coupled water, expressed as surface coverage w (i.e. adsorbed “wet” mass per 
unit area): �௪ = − ௖��௠                                                                                                                   (SI 2) 
where C is a constant based on the physical properties of the quartz crystal (C = 0.177 mg m
-2
 
Hz
-1
) and m is the overtone number (m = 1, 3, ...). However, the linear relationship between 
the adsorbed mass and Δf is invalid for hydrated layers characterized by high dissipation 
shifts, as in the case studied here. For such films, in order to calculate the adsorbed mass and 
viscoelastic properties, theoretical modeling is necessary.  
QCM-D data were modeled by the Voigt viscoelastic model
[8, 9]
 using the QTools 3.0 
software (Biolin).
[10]
 The frequency and dissipation changes recorded for five overtones were 
used for the modeling. The buffer density and the viscosity were fixed at 1000 g dm
-3
 and 1 
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mPa s
-1
, respectively. The films were modeled as homogeneous viscoelastic layers 
characterized by the acoustic thickness d, density ρ, and the frequency-dependent storage and 
loss moduli G’(f) and G”(f), respectively, as described earlier.[11, 12] The loss modulus can be 
calculated based on film viscosity η(f) from the equation G”(f) = 2πfη(f). It was assumed both 
G’ and G” are characterized by a power-law frequency dependence with critical exponents α 
and β, respectively (G’ ∝ fα and G” ∝ fβ). To extract the thickness and the viscoelastic 
properties of a film upon modelization, it is necessary to input the estimated film density. In 
contrast, the calculated surface coverage w, that is, the product density by thickness, remains 
largely unaffected for a broad range of density values. We confirmed that changing the film 
density between 1000 and 1700 g dm−3 essentially does not influence the surface coverage of 
the adsorbed film estimated through modeling. Once the surface coverage of the film is 
known, its density can be calculated by combining QCM-D and SPR data, as described below. 
This density value was lastly used in final modeling procedure to determine storage modulus, 
film viscosity and thickness. The parameters fitted were (i) the layer shear storage modulus 
G’(f) between 103 and 107 Pa, (ii) the layer viscosity η(f) between 0.001 and 0.1 kg m-1 s-1, and 
(iii) the layer density d between 10
-10
 and 10
-7
 m.  
Calculations of water content and layer density. Combining the dry mass per unit area 
d obtained by SPR and the wet mass per unit area w obtained by QCM-D, the mass fraction 
of water x in the film can be calculated from relation: � = 1 − Γ�Γ�                  (SI 3) 
Knowing the water content, the density of the adsorbed layer  can be estimated from the ideal 
mixing relation: ଵρ = ଵ−௫ρ� + ௫ρ�                                                                                                                       (SI 4) 
where s is the density of buffer, and p is the density of polymer.[13, 14] The densities of CH-
PC polymers were estimated from their partial specific volume calculated based on group 
contribution method
[15]
 as 1700, 1650, and 1600 g dm
-3
 for CH derivatives bearing 15, 25, and 
40 mol% of PC units, respectively. The value estimated by this method for unmodified 
chitosan (1770 g dm
-3
) agrees very well with the value determined experimentally by 
Errington et al. (p = 1770 ± 120 g dm-3).[16]  
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MCF-7 cell line observation by optical microscopy 
 
Figure SI.2.4 Optical micrographs of MCF-7 cells on CH-PC coated surfaces 1 day and 4 
days after seeding (micrographs A to C and E to G, respectively), and on polystyrene tissue 
culture plates (micrographs E and H); Scale bar: 200 ȝm. 
Aggregation of HUVECs 
 
Figure SI.2.5. Plot of the changes of N0/N as a function of time, where N is the number of 
objects per unit area at t, No is the initial number of objects per unit area, K is the rate constant 
of aggregation. (×) Stands for substrates coated with CH-PC25 films and (O) for substrates 
coated with CH-PC40 films. The solid line corresponds to the theoretical predictions (the two 
predictions cannot be distinguished at this scale) using equation (2). 
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CHAPTER THREE 
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Summary of transition 
In this chapter, synthesis and characterization of CH-PC-E2 polymer conjugate was 
performed as a prodrug strategy. The solution and interface properties of CH-PC-E2 polymer 
conjugate were also further explored. By a self-assembly bottom-up approach, CH-PC-E2 
films demonstrated hydrogel natures, and exerted cardiovascular protective effect through 
stimulating endogenous NO production. Coupled with ER-α binding study by QCM-D and 
cell culture-based DAF-FM fluorescence imaging study, biological properties of CH-PC-E2 
film were elucidated from protein to cell level. However, investigations with regards to the 
CH-PC-E2 films applications were not extensively conducted. For example, how CH-PC-E2 
films regulate proliferation and differentiation of cardiac stem cells, such as endothelial 
progenitor cell (EPC), could be carried out in future study. Moreover, CH-PC-E2 film-based 
toxicity test should be addressed in preclinical studies through discussion its risk to induce 
breast cancer proliferations (genomic action of E2). However, the cardiovascular protective 
characteristic of CH-PC-E2 hydrogel-liked film might be associated with non-genomic action 
of surface-tethered E2. As a result, the detailed non-genomic and genomic mechanisms of 
surface-tethered E2 will be discussed in the next chapter using micropatterned surface 
prepared by a top-down approach. 
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3.1 Abstract 
            Female steroid hormone estradiol (E2) activates the production of nitric oxide (NO), a 
signaling messenger that functions as an important vasodilator, and hence plays vital 
protective role in the cardiovascular system. However, estrogen replacement therapies in 
cardiovascular diseases were in dispute recently because: 1) insolubility of E2 in water limits 
its bioavailability; 2) supplementary of exogenous E2 may increase the risk of breast cancer. 
An effective strategy to solve these issues is to tether E2 to a hydrophilic polymer surface. In 
current approach, a new derivative of E2 (17α-ethinylestradiol-benzoic acid) was covalently 
tethered onto a chitosan phosphorylcholine (CH-PC) polymer backbone. The 17α-
ethinylestradiol-benzoic acid grafted CH-PC polymer conjugate (CH-PC-E2) was 
characterized by several techniques, such as 
1H nuclear magnetic resonance spectrometer (1H 
NMR), Fourier transformed infrared-attenuated total refraction (FTIR-ATR) and UV/vis 
spectra measurements. Moreover, the hydrogel nature of CH-PC-E2 conjugate was confirmed 
via a quartz crystal microbalance with dissipation (QCM-D) study, through discussion of its 
mechanical properties. To maintain the activities of surface-tethered E2 in the CH-PC 
backbone, a drop-casting method was used for a thin film formulation as a self-assembly 
bottom-up approach. The biological integrity of CH-PC-E2 film was further determined via an 
estrogen receptor-α (ER-α) binding experiment. In the EA.hy926 endothelial cell, CH-PC-E2 
thin film significantly stimulated the production of endothelium-derived NO, through an 
investigation of a diaminofluorescein-FM diacetate (DAF-FM) imaging study. These results 
indicate that the CH-PC-E2 thin film serves as an endogenous NO activator and implies its 
potential use in the cardiovascular regenerative medicine.  
3.2 Author Keywords 
Estradiol; Nitric oxide; Self-assembly bottom-up approach; Thin film formulation 
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3.3 Introduction 
            Estradiol (E2), a female hormone produced by ovary or adrenal glands, plays a vital 
role in the reproductive cycle and metabolism.
[1-3]
 In recent epidemiology studies, 
cardiovascular disease rates are significantly different between premenopausal and 
postmenopausal women, suggesting the cardio-protective effects of E2.
[4-6]
 In previous studies, 
it was demonstrated that direct local delivery of E2 can prevent neointimal hyperplasia, 
ameliorate late stent thrombosis, and reduce collagen accumulation.
[7-9]
 To date, both clinical 
observations and experimental evidences indicated that the cardio-protective effects of E2 is 
associated its non-genomic action, via binding to membrane-bound estrogen receptors (mERs) 
and activating endothelial nitric oxide syntheses (e-NOS) in cardiovascular system.[10, 11] The 
generated endogenous NO by E2 leads to arterial vasodilatation within the blood vessel and 
regulates various biochemical signal pathways in the cardiovascular system.
[12, 13]
 Moreover, it 
is also acknowledged that the high level of NO reduces platelet adhesion and prevents the 
development of atherosclerosis, which is a major cardiovascular complication that causes 
extremely high mortality rate.
[14-16]
 However, some factors may limit the direct applications of 
E2 in clinical trial. On one hand, poorly water-solubility performance of E2 largely affects its 
bioavailability in vivo. On the other hand, long-term use of E2 will trigger the genomic action 
and hence induce a higher risk of breast cancer occurrence.[17] Therefore, it is highly required 
to develop novel strategies, that maintains the presentation of E2 only approaching to the cell 
membrane site without triggering the genomic action to stimulate cancer cell proliferation.[18] 
Recently, an estrogen dendrimer conjugate (EDC) was developed by attaching of 17α-
ethinylestradiol (EE2) to a poly(amido) amine (PAMAM) dendrimer.
[19]
 In the cardiovascular 
system, EDC activated NO production via interacting with membrane ER-α without inducing 
breast cancer growth in vivo.
[20]
 However, some of recent studies also explored that PAMAM 
dendrimer is associated with high toxicity due to the high density of its surface charges, which 
may cause safety issues in a long-term frame applications as well.
[21, 22]
  
Prodrug strategy, an approach that covalently tethers drugs to a polymer scaffold, is 
promising for stimulating long-term frame biological responses.
[23, 24]
 In present study, the 
objective is to tether E2 to a polymer backbone surface as a novel prodrug for cardio-therapy. 
Chitosan is a natural polysaccharide composed of β (1-4) linked N-acetyl-D-glucosamine 
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residues, serving to inhibit neointimal hyperplasia in cardiovascular system.[25, 26] In our 
previous study, we found that the use of membrane-mimicking moiety phosphorylcholine 
(PC), to substitute certain amounts of primary amine in the chitosan backbone, demonstrated 
prominent biocompatibility nature.[27] In present study, an E2 derivative, 17α-ethinylestradiol-
benzoic acid (E2-benzoic acid), is prepared for covalently tethering to a CH-PC polymer 
backbone. A quartz crystal microbalance (QCM-D) experiment is performed to study the 
mechanical property and rheology of CH-PC-E2 conjugate. A CH-PC-E2 thin film will be 
formulated by drop-casting method to maintain the exposure of E2 at the topmost layer of the 
interface. The biological activity of CH-PC-E2 will be confirmed via an estrogen receptor 
binding experiment. Finally, in order to investigate the cardiovascular protective potentials of 
CH-PC-E2, a diaminofluorescein-FM diacetate fluorescence probe (DAF-FM) will be used to 
detect endogenous NO production by culturing a highly expressly estrogen receptor 
endothelial cell line (EA.hy926 cell) onto the CH-PC-E2 formulated thin film.
[28]
 The studies 
above will show that CH-PC-E2 may account, at least in part, for the noted beneficial actions 
on the cardiovascular systems. 
3.4 Experimental section 
3.4.1 Materials 
            Deionized water (18.2 MΩ·cm) was purified by a Millipore Milli-Q water purification 
system. 17α-ethinylestradiol (EE2) was purchased from Toronto Research Chemicals Inc. 
(North York, ON, Canada). 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), N-
hydroxysuccinimide (NHS), recombinant human estrogen receptor-α (ER-α), fulvestrant (ICI 
182,780) and 4-amino-5-methyl amino-2, 7ƍ-difluorofluorescein diacetate (DAF-FM) diacetate 
fluorophore were purchased from Sigma-Aldrich. Chitosan (CH) (molecular weight ranges 
from 50~100K) was purchased from Fisher Scientific Inc. The original degree of deacetylation 
(DDA) of chitosan is 88%. A further deacetylation reaction led to a higher DDA (~98%, 
determined by 
1
H NMR spectroscopy). Phosphorylcholine-glyceraldehyde (PC-CHO) was 
prepared by activation of L--glycerophosphorylcholine (purchased from Santa Cruz 
Biotechnology, Inc) as described previously.
[29]
 All other reagents and solvents were of a 
reagent grade and used as received.  
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3.4.2 Preparation of PC-substituted chitosan (CH-PC) 
            PC-substituted chitosan in a 20%  ratio (CH-PC20) was obtained by the procedure as 
described previously.
[29]
 Briefly, deacetylated chitosan powder (0.5 g, 3.1 mmol of 
monosaccharide unit) was fully dissolved in aqueous acetic acid (20 mL, 2 wt %). Then, a 
solution of PC-CHO (0.2g, 0.82 mmol) in water was added dropwise to the solution of 
deacetylated chitosan at 0 °C. The solution was stirred for 30 min and the pH was adjusted to 
6.5 by adding 1M aqueous NaOH. Thereafter, the reaction mixture was stirred for 24 h under 
ambient temperature. After the reaction, the solution was cooled to 0 °C. A solution of sodium 
cyanoborohydride (0.5 g, 8 mmol) in water (20 mL) was further added under stirring. The 
reaction mixture was stirred for 20 h again under ambient temperature. The reaction mixture 
was firstly dialyzed (membrane of MWCO 12,000-14,000 Da) against DI water for 2 days, 
then against 0.05 M NaOH aqueous solution for 1 day and finally against DI water for another 
2 days. The CH-PC20 polymer powder was finally isolated by freeze-drying for the further 
use (yield 0.4 g).  
3.4.3 Conjugation 17α-ethinylestradiol to 4-iodobenzoic acid 
            A derivative of 17α-ethinylestradiol (17-EE2) was synthesized by substitution of 
ethinyl group to phenyl group for the covalently immobilization to the CH-PC polymer. The 
synthesis protocol is briefly described below: [30] 17-EE2 (888 mg, 3.0 mmol) was added as a 
solid to a mixture of 4-iodobenzoic acid (744 mg, 3.0 mmol), 
bis(triphenylphosphine)palladium(II) dichloride [Pd(PPh3)2Cl2] (42 mg, 60 nmol) and CuI (22 
mg, 120 nmol) in 30 ml diethylamine solution under an inert atmosphere of nitrogen. The 
mixture was stirred at room temperature for 10 min and then heated to 65oC to reflux for 12 
hours. After cooling to room temperature, the mixture was separated into two layers. The light 
colour top layer was separated and evaporated to yield a dark red oil-like liquid. After that, 
this oil-like liquid was re-dissolved in water and acidified by a 1M HCl solution to form a 
slightly yellow solid product. Then, this solid product was filtered and washed with deionized 
water twice and dried in vacuum to form a brown colour solid. Finally, this brown solid was 
re-dissolved in sodium hydroxide solution and filtered to remove insoluble materials. The 
filtrate was further acidified by the 1M HCl solution to form a slight brownish solid. The 
 91 
 
slight brownish solid was collected by filtration and dried in vacuum to obtain the final 
product, E2-benzoic acid (yield: 800mg, 65%). The final product was characterized by a 
Bruker ARX-400 400 MHz 1H nuclear magnetic resonance spectrometer (1H NMR). 1H NMR 
(400 MHz, CDCl3): δ 0.79 (s, 3H), 1.12–2.78 (m, 15H), 6.43 (d, J = 2.9 Hz, 1H), 6.50 (dd, J = 
3.0 Hz, J = 8.5 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 7.35 (d, J = 8.6 Hz, 2H), 7.84 (d, J = 8.6 Hz, 
2H). Fourier transformed infrared-attenuated total refraction (FTIR-ATR) spectra were 
recorded on a Thermo Scientific Nicolet 6700 FTIR spectrometer with 32-time scanned 
interferograms at an 8 cm−1 resolution (see Figure SI.3.1). 
3.4.4 Preparation and characterization of CH-PC-E2 conjugates 
            A solution of E2-benzoic acid (11.65 mg, 0.028mmol) with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (9.55mg, 0.06 mmol) and N-hydroxysuccinimide (6.9mg, 
0.06 mmol) was added dropwise to the CH-PC (200mg) aqueous solution. After that, the pH 
of solution was adjusted to 9 by sodium bicarbonate. The reaction lasted for 24 hours and the 
product was dialyzed against DI water for 48 hours and then freeze-dried. The 1H NMR 
spectra of CH-PC-E2 sample were recorded on a Bruker ARX-400 MHz spectrometer at 70oC. 
UV/vis spectra were obtained using a Hewlett-Packard 8452A photodiode array spectrometer. 
Fourier transformed infrared-attenuated total refraction (FTIR-ATR) spectra of samples were 
recorded on a Thermo Scientific Nicolet 6700 FTIR spectrometer with 32-time scanned 
interferograms at an 8 cm−1 resolution (see Figure SI.3.2).  
3.4.5 Dynamic light scattering (DLS) measurements 
            For the solution of CH-PC or CH-PC-E2 preparation, CH-PC and CH-PC-E2 polymers 
were dissolved in PBS and then added a few drops of 1M aqueous HCl at a final concentration 
of 1.0 g L-1. The polymer solutions were stirred overnight under ambient temperature. The pH 
of the solutions was adjusted to 6.8 by adding a few drops of 1M aqueous NaOH. The 
resulting solutions were stirred overnight again at ambient temperature and filtered through 
0.45 ȝm PVDF filters. DLS experiments were performed in a fix angular at 90° by an 
ALV/CGS-3 instrument (ALV GmbH, Germany) equipped with a goniometer. The light 
source was selected by using a 22mW He–Ne laser (operating at a wavelength of Ȝ0 = 632.8 
nm), interfaced with an ALV-5000 multiple digital time correlator. The Stokes–Einstein 
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relationship was used for the calculation of hydrodynamic radius (Rh) from the diffusion 
coefficients. 
3.4.6 Spectroscopic ellipsometry analysis 
            The thicknesses of CH-PC or CH-PC-E2 films were determined by M-2000V multi-
wavelength ellipsometer (J.A. Woollam Co.) at an incident angle of 75° with a wavelength 
range of 370–1000 nm. The CH-PC or CH-PC-E2 films were prepared by casting 1.0 g L–1 
CH-PC or CH-PC-E2 polymer solutions onto the piranha cleaned silicon wafers (WARNING: 
see above) and dried overnight. After that, the films were then rinsed with copious deionized 
water and followed by air-drying. Each sample was carried out three independent 
measurements at different spots. The resulting spectra data were analyzed with the WVASE32 
software. The film thickness was estimated using the relation of Cauchy:  
      �ሺ�ሻ = �௡ + ஻��2 + ஼��4                                                                                       (1) 
where Ȝ is the wavelength and n is the refractive index, taken as 1.59, as previously 
reported.
[31]
 
3.4.7 Quartz crystal microbalance with dissipation (QCM-D) studies 
            Quartz crystal microbalance with dissipation monitoring (QCM-D) is a surface 
analytical technique simultaneous measurements of frequency changes (Δf) and energy 
dissipation change (ΔD) by applying external mechanical stresses periodically over the quartz 
crystal based on the piezoelectricity of quartz.
[32, 33]
 It measures the changes of adsorbed mass 
on the interfaces in nanogram scale which is linearly proportional to the frequency changes. In 
present study, QCM-D experiments were performed with a Q-sense E4 instrument (Biolin). 
QCM-D signals were recorded for the fundamental frequency as 5 MHz with six overtones 
(15, 25, …, 65 MHz). QCM silicon dioxide sensors (QSX-303, Q-Sense) were used for the 
CH-PC and CH-PC-E2 functionalization. Before the experiment, the silicon dioxide sensors 
were cleaned according to the suggestions by suppliers. Briefly, the silicon dioxide sensors 
were firstly treated by UV-ozone for 10 min. Then the sensors were subsequently immersed in 
2% sodium dodecyl sulphate solutions for 30 min and rinsed 5 times with deionized water. 
Finally, the sensors were dried with nitrogen and treated by UV-ozone for another 10 min.  
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            In order to obtain the information of viscoelastic properties, CH-PC-E2 and CH-PC 
were functionalized in situ of QCM-D instrument for overnight reaction. The protocol is 
shown as follow. A cleaned silicon dioxide sensor was firstly placed in the QCM-D sample 
holder. After flushing with PBS buffer to maintain the QCM-D signal baseline stable, a 
solution of CH-PC or CH-PC-E2 in PBS buffer with a concentration of 1.0 g L
–1 
was 
introduced into the QCM-D sample chamber at a flow rate of 10 ȝL min–1 at room temperature 
for overnight reaction, which mimics the same protocol for the glass substrate 
functionalization as subsequent cellular study. After that, the QCM-D sample chamber was 
flushed with the same buffer again to remove unbound polymer. In order to exclude solvent 
effect, the data recorded after removal of unbound polymers were used for modeling. The 
QCM-D data were fitted by using the Voigt viscoelastic model
[34, 35]
 with five independent 
overtones using the QTools 3.0 software (Biolin). The viscoelastic values including thickness 
d, storage modulus G’, loss modulus G” , critical exponents α’ and α”, were obtained using the 
parameters in detail as described previously.
[36]
  
            For the confirmation of the biological activity of rehydrated CH-PC-E2 film, we used 
ex-situ drop-casting method for the film deposition for the simulation of subsequent cellular 
study. The corresponding ER-α binding experiment was performed as following protocol. CH-
PC-E2 and CH-PC solutions in PBS with a 1.0 g L
–1 
concentration were drop-casted onto the 
cleaned QCM-D silicon dioxide sensors and dried overnight, respectively. Then, the sensor 
surfaces were washed with copious DI water and follow by air-drying again. For ER-α binding 
experiment, after flushing with PBS to establish a baseline, a solution of ER-α in a 
concentration of 50 nM was replaced through the measuring chamber at a rate of 10 µL min
-1
 
at room temperature for CH-PC or CH-PC-E2 functionalized substrates, respectively. When 
the frequency and dissipation reached constant values, excess unbound ER-α was removed 
subsequently by rinsing the sample chamber with PBS buffer again. The result in the plot was 
shown as the fifth overtone. For the calculation of the amount of adsorbed ER-α, the 
Sauerbrey equation: 
 = − ஼�௡                                                                                                        (2) 
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was used as previously suggested,[37] where  denotes as surface coverage of the adsorbed 
protein, Δf is linearly related to the mass of the adsorbed protein, C is a constant related to the 
physical properties of the quartz crystal (C = 0.177 mg m-2 Hz-1) and n is the overtone number 
(n = 1, 3, 5...).  
3.4.8 Cell culture 
The human vascular endothelial cell line EA.hy926 cells were obtained from American 
type culture collection (ATCC). The cells were maintained in Dulbecco's Modified Eagle's 
Medium (DMEM) with 10% fetal bovine serum at 37°C in a humidified atmosphere 
containing 5% CO2. The cells were subculture every 3 days using 0.25% trypsin-EDTA.  The 
cell culture medium was replaced with phenol red-free DMEM 24 hour in advance and then 
the cells were starved another 6 hour before the cell fluorescence imaging experiment. For the 
fluorescence imaging study, cells were harvested and loaded in HBSS buffer containing 10µM 
DAF-FM for 30 min at a density of 5x10
5
/ml. Then the DAF-FM labeled cells were replaced 
by HBSS buffer containing with or without 10 µM ICI 182,780 for 1 hour incubation. Finally, 
the cells were seeded into CH-PC-E2 or CH-PC surfaces for 1 hour incubation and performed 
fluorescence cell imaging study. 
CH-PC and CH-PC-E2-coated glass substrates were prepared by drop-casting 1 mg 
mL
-1
 CH-PC or CH-PC-E2 solutions onto the glass-bottom (MatTek) dish for overnight 
reaction at ambient conditions. Then, the polymer-coated glass substrates were washed with 
copious DI water and follow by air-drying. Before cell seeding, the polymer-coated glass 
substrates were sterilized with 75% ethanol, and followed by washing with PBS buffer and 
conditioning in the cell culture medium. 
3.4.9 DAF-FM fluorescence imaging study 
DAF-FM is a sensitive fluorescent probe for NO detection at a nanomolar scale.
[38]
 
Initially, DAF-FM shows weak fluorescence signals. However, after acetate hydrolyzing and 
subsequently reacting with produced NO in cells, DAF-FM transforms to a highly fluorescent 
benzotriazole derivative. The cell loaded substrates as stated above were placed on the IX81 
microscope (Olympus). Fluorescence images were acquired by and controlled by the 
MetaMorph imaging System (Molecular Devices) using a 10X-fluor objective at excitation 
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and emission wavelengths of 488 and 535 nm, respectively. Each sample was prepared in 
triplicate. The fluorescent intensity of cells was analyzed by using the image analysis software 
Image Pro Plus (Media Cybernetics), and average fluorescent intensity of total cells per image 
was obtained by analyzing the best fit circular region of interest. Standard deviations are based 
on calculations for three independent samples. 
3.4.10 Statistics 
All statistical analysis was performed using SPSS 18.0 software. Statistical differences 
among each group were assessed by a Student’s paired t-test. Probability values of p < 0.05 
were considered significant and represented as asterisk (*). All data are presented as mean ± 
standard deviation. 
 
 
 
 
Figure 3.1 Synthetic route of CH-PC-E2 polymer conjugate 
+
NHS, EDC
CH-PC-E2
Pd(PPh3)2Cl2
CuI
Diethylamine
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3.5 Results and discussion 
3.5.1 Characterization of CH-PC-E2 conjugates 
            In this study, E2-benzoic acid was covalently tethered to CH-PC via an amide linker. 
The synthesis strategy for the preparation of CH-PC-E2 conjugates involved two steps (Figure 
3.1): (1) selective modification of ethinyl group of 17α-ethinylestradiol with 4-iodobenzoic 
acid linker, which was further activated to corresponding N-hydroxysuccinimide (NHS) ester; 
(2) Conjugation of E2-benzoic acid to CH-PC polymer backbone via formation of an amide 
bond. PC-modified chitosan polymer backbone was synthesized via conjugation of PC-
glyceraldehyde to deacetylated chitosan.[39] The content of PC groups was ~20 mol %, 
calculated from 1H NMR data.[29] As shown in Fig.3.2, the 1H NMR signal of CH-PC 
backbone was labeled from C1 to C5, respectively. The successful conjugation of E2-benzoic 
acid was particularly validated by the appearance of a signal at 1.30 ppm, attributed to the 
resonance of methyl protons of ethinylestradiol (E18). The 1H NMR signals at 7.67 ppm, 7.14 
and 7.06 ppm assigned to the resonance of aromatic protons of E2 residues (E1, E2 and E4). 
The aromatic protons of iodobenzoic acid linker were also shown at 8.23 ppm and 7.92 ppm, 
respectively. 
 
 
. 
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Figure 3.2 
1
H NMR spectrum of CH-PC-E2 conjugate in D2O at 70
o
C. 
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3.5.2 Viscoelastic properties of CH-PC-E2 and CH-PC formulated thin films  
When considering the application of biomaterials in the cardiovascular regenerative 
medicine, viscoelastisity is one of the most important mechanical properties, including the 
storage modulus G’, which reflects the elastic property, and the loss modulus G”, which 
represents the viscous property.[40-43] Complex shear modulus G, representing to the resistance 
of materials to deformation, can be represented as G = G’ + iG”, where i is the imaginary 
unit.[33] QCM-D is a useful surface analytical tool to study the properties of the soft films 
depositing on the surfaces in real time. The parameters measured by QCM-D, resonance 
frequency (Δf) and dissipation (ΔD), reflected the mass of adsorbed molecules and their 
viscoelastic properties.[32]  
In present study, the QCM-D resonance frequency and dissipation shifts for CH-PC-E2 
and CH-PC were recorded in a time-dependent manner as indicated in the Fig.3.3 (A). For 
both of the CH-PC (black trace) and CH-PC-E2 (red trace) adsorption, the QCM-D signals 
reached a plateau of the frequency at ca. −20 Hz and of the dissipation at 1.7× 10-6 after 2 
hours. The results were fitted using Voigt viscoelastic model as shown in Table 3.1. The 
thickness of CH-PC-E2 film is in a similar range of CH-PC film (CH-PC-E2: 4.7±1.7 nm vs. 
CH-PC: 3.9±0.8 nm). This films thickness value measured by QCM-D study is also 
accordance well with the thickness value measured by ellipsometry formed by drop-casting 
method (CH-PC-E2: 3.1±0.2 nm vs. CH-PC: 2.6±0.1nm).  
G’ and G” are governed by power laws with scaling exponents α’ and α”, and 
proportional to the angular frequency of deformation ω, as shown follow: G’ (ω) = G0’ (ω / ω 0) 
α’, G” (ω) = G0” (ω / ω0) α”, where ω 0 is the reference frequency.[44]  Scaling exponents α’ 
and α”, reflect microscopic motions within material.[45] As shown in the Figure 3.3(B) and 
Table 3.1, the estimated loss and storage moduli, and the scaling exponents (α’, α”) of CH-PC 
and CH-PC-E2 films demonstrated a typical of hydrogel nature within a range of MPa (G’> 
G”, 0<α’<1, 0<α”<1). The hydrogel formation is probably due to the crosslinking via ionic 
pairing within PC groups. Considering the identical value of rheological characteristic of CH-
PC and CH-PC-E2 hydrogel films, it suggests that the hydrophobic interactions among E2 
microdomains are weak and apparently didn’t significant affect the mechanical properties of 
films. Moreover, the elastic modulus of CH-PC and CH-PC-E2 hydrogel films are in the 
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similar magnitude of cardiac regeneration materials, such as chitosan gelatin hydrogel 
(~0.3MPa)
[46]
 or Dacron (~0.6MPa)
[47]
.  
 
Figure 3.3 QCM-D study of in situ formed CH-PC-E2 and CH-PC hydrogel films on the 
silicon dioxide for overnight reaction at 25oC. (A) The shift of QCM-D frequency (Δf5/5) and 
dissipation (ΔD5/5) showed the thin film formulations of CH-PC (black trace) and CH-PC-E2 
(red trace) onto the silicon dioxide surfaces as a function of time. (B) The storage modulus 
(squares) and loss modulus (circles) of CH-PC and CH-PC-E2 hydrogel films are shown in a 
frequency dependent manner.  
 
Table 3.1 Viscoelastic properties of CH-PC and CH-PC-E2 hydrogel films formed in situ a 
Polymer
 
Thickness (nm) G’(MPa) G”(MPa) α’ α” 
 
CH-PC 
3.9±0.8
 
0.66 0.62 1.04 0.55 
CH-PC-E2
 
4.7±1.7
 
0.73 0.57 0.68 0.78 
a
 G’ and G”: hydrated layer storage and loss moduli (represented values at 25 MHz) measured 
by QCM-D. α’ and α”: scaling exponents calculated based on the frequency dependence 
power-law for G’ and G”, respectively.  
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3.5.3 The binding experiment of ER-α to CH-PC-E2 hydrogel film 
QCM-D techniques are flexible to provide additional biologically relevant information, 
which can mimic the protein interactions with surfaces under real physiological conditions.
[48]
 
In the previous study, estrogen receptor element (ERE) was immobilized onto a QCM-D 
sensor surface in order to study its interactions with ERs as well as to understand the relevant 
biophysical properties, such as the bound ER-α conformation and orientation.[49, 50] Herein, 
QCM-D based ER-α binding experiment is carried out onto the CH-PC-E2/CH-PC thin film-
functionalized QCM sensor prepared ex-situ using the same strategy as the strategy of 
subsequent cellular studies. 
In the QCM-D related protein adsorption study, the frequency shift is proportional to 
the mass changes of the CH-PC-E2/CH-PC films induced by protein adsorption while the 
dissipation shift is relevant of internal energy loss within the adsorbed estrogen receptor 
protein films with respect to periodic damping.
[51]
 In this study, it generally demonstrates the 
Δf and ΔD responses as a function of time for the ER–α binding to the CH-PC-E2-
functionalized QCM-D glass crystal sensor (red trace). Control experiments were performed in 
the CH-PC functionalized control surfaces for the comparison (black trace). In the frequency 
and dissipation shifts versus time curves as shown in the Fig.3.4 (A), the stable baseline 
gradually changed upon flowing over 50 nM of ER-α solution onto the CH-PC-E2 
functionalized QCM sensor, indicating a constant protein mass accumulation onto the surface. 
After PBS flushing, the QCM-D frequency and dissipation signal was stabilized at the value of 
−27 Hz and 3.3×10-6, respectively. However, we can also observe that the flowing through of 
ER-α solution over CH-PC control surface didn’t trigger significant QCM-D frequency and 
dissipation signal changes. By applying the Sauerbrey model as previously suggested 
[52]
, the 
surface coverage of ER-α for CH-PC-E2 films is ~6.26±0.51 mg m-2.  
The adsorbed ER-α layer can also be considered as a viscoelastic film, reflecting the 
conformation and binding energies to the surface.
[53]
 Smaller dissipation value per mass unit 
indicates that the protein layer forms a dehydrated and a well-packed rigid arrangement while 
larger dissipation value per mass unit demonstrates a lower protein binding strength and a 
highly extended and hydrated protein arrangement
[54, 55]
. The ΔD-Δf correlation indicates how 
dissipation changes upon surface coverage of ER-α independent on time.[50] According to 
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previous studies, the dissipation to frequency ratio (the slope of ΔD to Δf curves) reflected the 
conformational information of adsorbed ER-α layer, which hence can distinguish the specific 
and non-specific ER adsorption.
[54, 55]
 From the Fig.3.4B, the ΔD to Δf curves of ER–α binding 
onto the CH-PC films showed in a linear relationship, suggesting that ER–α didn’t undergo 
significant conformational changes with regard to the accumulation of ER–α coverage. 
However, the ΔD to Δf curves of ER–α binding onto the CH-PC-E2 films display two 
distinctive features (the transition point is indicated in the Figure 3.4B). At the initial stage (Δf 
<6 Hz), the slope of ER–α adsorption onto the CH-PC-E2 film showed a similar manner as 
CH-PC film, indicating that non-specific of ER–α adsorption is dominant. However, the slope 
of the ΔD to Δf plot decreased after sufficient amounts of ER–α adsorption (Δf >6 Hz), 
suggesting a formation of a more dehydrated and rigid ER–α layer (specific adsorption), 
which is well accordance with previous study.
[49]
 As a result, we can assume that CH-PC-E2 
films will be energetically favorable to interact with estrogen receptors around cell membrane 
considering into future cellular studies.  
 
Figure 3.4 ER-α adsorption experiment onto the CH-PC-E2 and CH-PC functionalized silicon 
dioxide sensor by QCM-D at 25oC. The time of ER-α (concentration: 50 nmol L–1) addition 
and PBS wash are indicated by the arrows. (A) The QCM-D frequency (Δf5 /5) and dissipation 
(ΔD5 /5) shift showed the adsorption of ER-α onto the CH-PC film (black trace) and CH-PC-
E2 film (red trace) and as a function of time. (B) ΔD-Δf plots for ER-α adsorption corresponds 
to the ER-α non-specific adsorption of the CH-PC film (black trace) to the specific adsorption 
of the CH-PC-E2 film (red trace). 
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3.5.4 CH-PC-E2 hydrogel film promotes intracellular nitric oxide (NO) 
production 
            The availability of NO enhanced vascular dynamics of the artery as well as inhibited 
platelet adhesions and smooth muscle cells proliferation. Currently, NO-based therapies are 
widely associated with using a nitrous oxide donor, sodium nitroprusside (SNP), in order to 
deliver therapeutic amounts of NO for the vascular regeneration
[56]
. However, in vivo 
metabolism process of SNP leads to cyanide release and formation of peroxynitrite, which 
induced high cellular toxicity.
[57]
 Locally delivery of E2 can exclusively stimulate endogenous 
NO production, which might provide a relative more biological friendly strategy for NO-based 
therapy.
[58]
  
            In order to determine whether CH-PC-E2 hydrogel films stimulate intracellular NO 
production, DAF-FM dia a cell permeable reagent, was used. Initially, DAF-FM has no 
fluorescent until they diffused across the cell membrane. Then, they were hydrolyzed by 
intracellular esterases and reacted with NO to transform to a fluorescent benzotriazole.
[59]
 As 
shown in the Fig.3.5, microscopic images (A-C) and corresponding fluorescence images (D-F) 
were obtained from culturing EA.hy926 cells on the CH-PC and CH-PC-E2 films 
functionalized glass substrates, respectively. DAF-FM fluorescently-labeled NO was observed 
throughout the region of a cell. The green regions reflect accumulated intercellular distribution 
of NO resulting from local NO productions. By analyzing the fluorescence intensities, we 
found that the CH-PC-E2 hydrogel-like film significantly stimulated higher NO release (1.65 
times) compared to the CH-PC films. Moreover, the increment was diminished in the cells 
pre-treated with estrogen receptor inhibitor ICI 182,780. The results confirmed that the NO 
production by CH-CP-E2 film is specifically due to the E2-ER interactions. Hence, the 
application of CH-PC-E2 film may extend the applications from novel local E2 delivery 
platform to the long-term functional coating materials for medical devices, e.g. stent, that 
serves to inhibit neointimal hyperplasia. 
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Figure 3.5 DAF-FM fluorescence imaging study of EA.hy926 cells incubated on the CH-PC 
and CH-PC-E2 films for 1 hour. Nitric oxide production levels were determined by using 
DAF-FM for the CH-PC functionalized substrates (A&D), CH-PC-E2 functionalized 
substrates (B&E), and CH-PC-E2 functionalized substrates pretreated with ICI 182,780 (C&F) 
for 1 hour. The top panels correspond to phase contrast micrographs and the bottom panels 
correspond to DAF-FM fluorescence images from the identical sites. (Scale barμ 100ȝm). The 
quantitative NO production levels were also shown by analyzing the emission peak intensity 
(G). Data were calculated by three independent samples. Probability values were considered 
significant which are represented as *p < 0.05. 
CH-PC CH-PC-E2 CH-PC-E2+ ICI 182,780
0.0
0.5
1.0
1.5
2.0
R
e
la
ti
v
e
 f
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 *(G)
 104 
 
3.6 Conclusions 
            The research described in present study is to graft E2 to the chitosan 
phosphorylcholine (CH-PC) polymer backbone for the preparation of CH-PC-E2 conjugate as 
a prodrug strategy. It was successfully demonstrated that the fabrication method significantly 
influenced mechanical properties, depth-dependent composition, and biological responses of 
CH-PC-E2 hydrogel like films. The protective effect of CH-PC-E2 hydrogel film in 
cardiovascular system was conducted via investigated with corresponding mechanism of NO 
stimulation. The further mechanism of CH-PC-E2 hydrogel film as a platform for the 
cardiovascular regenerative medicine, e.g. to enhance the reendothelialization process or 
promotes the recovery of the endothelium, will be carried out in future study. 
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3.9 Appendix B. Supporting information  
Synthesis and characterization of 17α-ethinylestradiol benzoic acid  
In order to covalently conjugate E2 to the surface, a derivative of 17α-ethinylestradiol 
(17-EE2) was used by coupling 4-iodobenzoic acid to ethinyl group. The biological activity of 
E2 has be shown to retain by a similar benzoic modification of 17-EE2 in previous study. The 
successful selective benzoic group of EE2 was confirmed by analysis of the 
1
H NMR 
spectrum of the reaction product (Figure SI.3.1), which presents the peak at δ 7.84 (a) and δ 
7.35 (b) ppm, attributing to the phenol proton of the new linker, while the peak at δ 6.λ8, 6.50 
and 6.43 ppm, attributing to the proton in the EE2 original phenol ring, respectively (1, 2, and 
4 site). A further evidence for the formation of the carboxyl group was obtained from the 
ATR-FTIR spectrum which displays a band at 1705 cm
-1
 for C=O stretching and a broad band 
at 3382 cm
-1 
for O-H stretching.  
 
Figure SI.3.1 Synthesis and characterization of 17α-ethinylestradiol benzoic acid for the 
surface immobilization. (A) Synthetic route of the 17α-ethinylestradiol benzoic acid. (B) The 
1H NMR spectrum of the 17α-ethinylestradiol benzoic acid in CDCl3 at 25oC. (C) The ATR-
FTIR spectrum of the 17α-ethinylestradiol benzoic acid at 25oC. 
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Characterization of CH-PC-E2 by ATR-FTIR  
In order to further confirm the covalent bond formation between E2-benzoic acid and 
CH-PC polymer backbone, FTIR-ATR spectra of CH–PC and CH-PC-E2 were also shown in 
the Fig.SI. 3.2. An evidence for the formation of the amide bond between ethinylestradiol and 
amine group was obtained from the CH-PC-E2 spectrum(red) , which displays a band at 1725 
cm-1 for C=O stretching. Both samples showed the characteristic bands at 3300 cm−1, 
attributed to the stretching vibrations of –NH2 and –OH groups in the chitosan backbone. 
Further, the successful conjugation of PC group in the chitosan backbone was confirmed by 
the presence of the four-band signature explained as following. The band at 1224 and 793 
cm−1 correspond to the anti-symmetric stretching of PO2− and P (OC) 2 moieties, while the 
band at 1065 cm−1 corresponds to the stretching of P–O–C moiety. Moreover, the band at 1369 
cm−1 corresponds to the bending of N+ (CH3)3 groups. 
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Figure SI.3.2 ATR-FTIR spectra of CH-PC (black) and CH-PC-E2 (red). 
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E2 contents in CH-PC-E2 measured by UV/vis 
The substituted content of E2 in the CH-PC-E2 polymer conjugates was determined by 
UV absorbance at 280 nm. As shown in the Fig.SI.3.3, 17α-ethinylestradiol in a concentration 
of 5×10-4 M in acetonitrile showed two signal peaks of absorbance in UV at 203 nm and 282 
nm (black trace). However, after grafting onto the CH-PC polymer, the two signal peaks are 
shifted to 201 and 270 nm in a water/acetonitrile (55:45, v: v) solvent (pH 6.8), respectively 
(red trace). The content of E2 residues (%) in the CH-PC-E2 polymer conjugates was 4.7 
mol% calculated by using Beer–Lambert law from the UV absorbance at 270 nm.[1] 
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Figure SI.3.3 UV absorbance of CH-PC-E2 polymer conjugates in H2O/acetonitrile (55:45) at 
pH 6.8. 
 
Dynamic light scattering (DLS) measurement 
            In aqueous solution phase, CH-PC tends to form self-aggregates due to the occurrence 
of electrostatic interactions between the amine groups and the PC moiety. In addition, CH-PC-
E2 may behave similarly due to two driving forces as synergistic effects: 1) the weaker 
electrostatic interaction between zwitterionic PC group and positively charged amine groups; 
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2) the hydrophobic/hydrophilic interactions of hydrophobic E2 residues and hydrophilic CH-
PC main chains. In the Fig.SI.3.4, dynamic light scattering (DLS) confirmed that both CH-PC-
E2 (Rh ~63nm) and CH-PC (Rh ~89nm) conjugate in solution form aggregates.  
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Figure SI.3.4 DLS measurement and size distribution (weight by intensity) of CH-PC (black 
trace, polydispersity index: 0.27±0.1) and CH-PC-E2 (red trace, polydispersity index: 0.17±0.1) 
aggregates in the PBS solution (pH~6.8) at 25oC.  
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Summary of transition 
In this chapter, E2 was functionalized to the micropatterned substrates, which are 
prepared by photolithography using top-down approach. Together with XPS, SPR and QCM-
D measurements, it proved that E2 was successfully tethered to a selected gold surface. 
Through cell ELISA studies, a conclusion that surface-tethered E2 can exclusively act as 
selective estrogen receptor modulators (SERM) to isolate E2 non-genomic action from cross-
talked signaling pathways was further validated. This micropatterning design allows us to 
understand the fundamental biological mechanisms of surface-tethered E2 in depth. However, 
the increased ERK phosphorylation level induced by E2-functionalized micropatterned 
substrate is only 18.7% in the present studies. In future, we expect to see larger responses by 
using higher gold dot densities of micropatterned substrates for E2 functionalization. 
Moreover, the other possible estrogen related non-genomic signal pathway, such as PI3K/ 
AKT,  should be addressed to validate the role of surface-tethered E2 in vitro and in vivo by 
using this biosensor-based technology. The results in this study were also accordance well 
with the previous chapter of CH-PC-E2 studies by different means of approaches (top-down vs. 
bottom-up) and biological studies (fundamental mechanisms of surface-tethered E2 vs. 
cardiovascular protective applications of surface-tethered E2). 
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4.1 Abstract 
            In addition to its major role in the regulation of gene expression-mediated processes in 
the nucleus, estradiol (E2) activates also transient non-genomic pathways through interactions 
with receptors located on the cell plasma membrane. The mechanism of the latter signaling 
remains poorly understood due to difficulties in preventing the entry of E2 in the cytoplasm 
and its subsequent transfer to the nucleus. A solution to this problem is presented in this report 
of the preparation of micropatterned substrates consisting of arrays of gold dots bearing 
tethered E2 were distributed on a glass substrate rendered cell-adhesive via covalent linkage of 
cyclic-RGD (cRGD) of short PEG chains. The E2 immobilization process and its 
physiological relevant activity were validated with surface plasmon resonance (SPR) and 
quartz crystal microbalance with dissipation (QCM-D) measurements carried out standard 
gold surfaces functionalized by an identical procedure and by cell proliferation studies on 
cRGD-modified glass substrates. MCF-7 cells attached to micropatterned substrates were 
shown to undergo phosphorylation of the extracellular signal-regulated kinase (ERK), an 
essential kinase of the E2 non-genomic pathway, without change in cell proliferation. These 
results demonstrate that the E2-modified micropatterned substrates can serve as non-genomic-
selective estrogen modulators, leading the way towards unveiling detailed features of the non-
genomic signaling of E2 and related estrogenic molecules. 
4.2 Authors keywords 
 Micropatterning; Estrogen; Non-genomic pathway; ERK; SPR; QCM-D   
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4.3 Introduction  
            The biological effects of 17β-estradiol (E2), the most potent and dominant estrogen, 
are mediated through estrogen receptors (ERs) acting as ligand-activated transcription factors. 
The hormonal effects of E2, known as genomic effects of E2,
[1]
 which take place over several 
hours to several days, are initiated through interactions of this steroid with ERs present in the 
nucleus. E2 is involved also in the regulation of various cellular processes, such as cell 
proliferation, migration, and differentiation.
[2]
 In addition, E2 exerts beneficial effects on the 
cardiovascular system.  For instance, it stimulates the release of nitric oxide, contributes to the 
repair of injured blood vessels, and lowers the risk of atherosclerosis.
[3]
 It is generally 
recognized that these effects are not initiated in the cell nucleus, but through interactions of E2 
with estrogen receptors localized on the cell plasma membrane, known as mERs.
[4-6]
 The 
extra-nuclear or “non-genomic” effects of E2 take place in the course of a few seconds to a 
few minutes.
[7-12]
 There have been indications, though, that in some cases E2-induced extra-
nuclear activation persists over much longer periods, up to ~16 hrs.
[13]
 This confusing state of 
affairs is brought about by the inherent difficulties of mechanistic studies involving non-
genomic effects of E2.
[14]
 For example, E2 has a very low solubility in water, therefore it is 
usually added to cell culture media as a solution in dimethylsulfoxide. This cosolvent remains 
in the media throughout the biological testing and may affect the outcome of the studies.
[15]
 
Also, it is critical to ensure that E2 interacts only with mER and does not enter the cell. One 
strategy to overcome these difficulties consists in linking E2 to large soluble proteins, such as 
bovine serum albumin (BSA)
[16]
 or peroxidase,
[17]
 or to synthetic macromolecules, such as 
poly(amido)amine dendrimers.
[18-20]
 E2 macromolecular conjugates are soluble in cell culture 
media, hence a cosolvent is no longer required. It is thought also that, in view of their size and 
physicochemical properties, E2-conjugates do not transit through the cell membranes.
[21]
 This 
may not always be the case. For instance, the estrogen-dendrimer-E2 complex was detected in 
the cytoplasm of treated cells even though the dendrimer was expected to be too hydrophilic to 
penetrate lipid bilayers.
[20]
 Intriguing evidence  about the location of the E2-dendrimer 
conjugate calls for a re-evaluation of previous results
[22]
 and, in the broader perspective, points 
to the need for better diagnostic tools.   
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            Covalent immobilization of biosignaling molecules to solid substrates is a well-
established tool to study biological effects induced by contact of signaling agents with 
receptors located on the plasma membrane.
[23-30]
 In the case of E2, which can act both at the 
level of the plasma membrane (outside the cell) and within the cytoplasm and the nucleus, 
immobilization onto a solid substrate via a non-cleavable covalent bond would allow one to 
monitor non-genomic pathways exclusively and unequivocally. Based on this premise, we set 
about to design and fabricate solid substrates that can be used to induce cellular responses 
known to involve specifically the interaction of E2 with mERs. Among various possible 
approaches, we opted for a micropatterned substrate consisting of arrays of micron-sized 
islands functionalized with E2 distributed within a cell-adhesive domain. Such bifunctional 
surfaces can be obtained by chemical modification of glass substrates arrayed with gold dots, 
using gold- and glass-specific chemical reactions to attach E2 to the gold islands and a cell-
adhesion promoter to the glass. Of course, the gold islands need to be small, compared to the 
size of cells, so that they do not prevent cell adhesion on the patterned substrates. The work 
described in this report led us to construct micropatterning surfaces useful for the study of E2 
non-genomic effect.  
            The feasibility of the approach was established first on two model substrates, namely 
glass slides functionalized with cell-adhesion promoters and gold substrates bearing E2 on 
their surface. Several cellular and physical techniques were used to monitor the chemical 
modifications performed on the two types of substrates and to test their functionality.  A cell 
adhesion test was employed in the case of the glass substrate. To study the attachment of E2 to 
gold and to test the ability of tethered E2 to interact with mER, we used surface plasmon 
resonance (SPR) spectroscopy, which allows one to determine the optical thickness of layers 
deposited on gold
[31]
 and quartz crystal microbalance with dissipation (QCM-D), which senses 
the total mass deposited on a vibrating quartz crystal and is often used for studying protein 
adsorption.
[32]
 Subsequently, micropatterned substrates were prepared and their ability to 
activate the phosphorylation of extracellular regulated kinase (ERK), an essential enzyme of 
the non-genomic pathway,
[33]
 was assessed by cell enzyme-linked immunosorbent analysis 
(ELISA) and cell proliferation assays. These biological assays, together with the physico-
chemical evaluations of homogeneously modified substrates, indicate that E2-patterned 
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substrates are powerful and versatile tools to assay cellular mechanisms initiated via receptors 
located on the plasma membrane. 
4.4 Materials and methods  
4.4.1 Materials 
            17α-ethinylestradiol was purchased from Toronto Research Chemicals Inc (North York, 
ON, Canada). 17α-ethinylestradiol-benzoic acid  (E2-benzoic acid) was prepared as described 
in a following a known procedure.
[19]
 Hereafter, we will call this compound E2 for the 
simplicity. ER-α, 2-chloro-4, 6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine 
(NMM) were purchased from Sigma (MO, USA). Amino-terminated linear RGD (Gly-Arg-
Gly-Asp-Ser) and cyclic RGD (Product name: cyclo[Arg-Gly-Asp-D-Phe-Lys(PEG-PEG), 
M.W. 894.0]) were purchased from the Peptide Institute (Japan) and Peptide International (KY, 
USA), respectively. The Hoechst 33342 staining kit was purchased from Life Technologies 
(CA, USA). Amino-PEG2k-thiol and NHS-PEG2k-trimethoxysilane were purchased from 
NANOCS (NY, USA). PEG2k-triethoxysilane was synthesized based on the literature 
method.
[34]
 Anti-phospho-ERK1/2 antibody was included in the cell-based ERK1/2 
(T202/Y204) ELISA kit purchased from Raybiotech (GA, USA). Other chemicals and 
reagents were of analytical grade and used as received.  
4.4.2 Cell culture 
            MCF-7 human breast cancer cells (HTB-22TM) were purchased from the American 
Type Culture Collection (ATCC) and were routinely cultured in Eagle’s Minimum Essential 
Medium (MEM, Sigma Aldrich), supplemented with 10% (v/v) fetal bovine serum (FBS, 
BioWest, France), 2 mM L-glutamine (Wako, Japan), 1 mM sodium pyruvate (Wako, Japan), 1% 
non-essential amino acids (Gibco, USA), and 1% penicillin-streptomycin (Wako, Japan), in a 
humidified atmosphere (5% CO2 and 95% air) at 37oC. For the cell ELISA studies, the cells 
were starved based on the protocol described by Hamelers et al.[35] In brief, the cells grown to 
the 50% confluence in the above-mentioned culture medium were conditioned with phenol 
red-free DMEM/F12 (Life technologies, USA) containing 5% charcoal-stripped FBS (Life 
technologies, USA) for 24 hrs. Then the cells were starved with the DMEM/F12 supplemented 
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with 0.2% bovine serum albumin (BSA, Wako), 30 nM sodium selenite (Sigma Aldrich, USA), 
10 µg/ml of transferrin (Sigma-Aldrich, USA), and 2 ng/ml of insulin-like growth factor type I 
(Life Technologies, USA) for 24 hrs. For the cell proliferation assay, cells were conditioned in 
phenol red-free DMEM containing 10% charcoal-stripped FBS for one week and starved in a 
serum free medium for 24 hrs. 
4.4.3 Glass surface modification and characterization 
            Glass coverslips (2.2 x 2.2 cm, 0.13–0.17 mm thick, Matsunami, Japan) were cleaned 
and activated in a UV-ozone cleaner (UV253, Filgen; O2: 6 L min-1, 0.1 MPa) for 1 hr. The 
substrates were transferred into a solution of NHS-PEG2k-silane (0.2 mg/mL) and PEG2k-
silane (0.2 mg/mL) in 1:9 v:v toluene: 0.01% acetic acid and kept at 80oC overnight. At the 
end of the reaction, the PEGylated substrates were washed with toluene 5 times, sonicated for 
5 mins in toluene and washed once more with toluene, followed by a similar treatment with 
methanol, after which the substrates were dried under a flow of nitrogen. For the linear RGD 
(lRGD) and cyclic RGD (cRGD) functionalization, the PEGylated substrates were covered 
with a 10 µl aliquot of a solution of lRGD or cRGD in phosphate buffered saline (0.5 mM, 
PBS) and placed on a teflon plate. The substrates were kept at room temperature overnight in a 
petri dish sealed with parafilm and wet tissues to prevent water evaporation. The recovered 
lRGD or cRGD modified substrates were washed with 3 times with PBS and treated for 2 hrs 
with a 0.5 mM solution of aminoethanol in PBS to quench unreacted NHS groups. Finally, the 
substrates were washed thrice with water and dried under a flow of nitrogen.  
            MCF-7 cells were seeded onto the lRGD or cRGD modified glass surfaces at a density 
of 20,000 cells/ml. After 1 hr cultivation, the cells were stained with Hoechst and cell counting 
was performed by observation with an Axiovert 200 fluorescence microscope (Zeiss, 
Germany) equipped with a charge-coupled device camera (Rolera-MGi, Q-imaging, Canada). 
Data were compared for significance of differences using the student’s t-test.  
4.4.4  Gold surface modification monitored by XPS, SPR and QCM 
            Angle resolved X-ray photoelectron spectroscopy (AR-XPS) measurements were 
performed on a Theta Probe X-ray photoelectron spectrometer (Thermo Fisher Scientific, 
Waltham, MA) equipped with a monochromatic Al K X-ray source (1486.6 eV) and a low-
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energy flood gun for charge compensation. The beam spot size was 400 ȝm. XPS survey 
spectra were collected at 65° takeoff angle, representing the angle of electron path between the 
analyzer and the sample surface. The narrow scans of C 1s and N 1s spectra were obtained by 
a pass energy of 40 eV, a step size of 0.1 eV, with a dwell time of 50 ms. All spectra were 
internally referenced by setting the hydrocarbon (C–C/C–H) component peak at 285.0 eV. 
            Surface plasmon resonance (SPR) measurements were performed using a computer-
controlled SPR Navi-200 model instrument (Bionavis, Finland). SPR gold-coated sensors 
(Bionavis, Finland) were cleaned with a piranha solution containing 70 % concentrated 
sulfuric acid and 30 % (v/v) hydrogen peroxide (35 %) (WARNING: Piranha solution is 
extremely reactive and must be handled with extreme caution.). The cleaned sensors were 
rinsed with deionized water, dried under nitrogen, and immersed in a 0.5 mM amino-PEG2k-
thiol ethanol solution gently swirled overnight. Subsequently, the PEG-modified sensor was 
washed thrice with ethanol, dried with nitrogen and placed in the mixture solution containing 
EE2-benzoic acid (1.2 mg) and CDMT (0.9 mg), which were dissolved in 1 mL dry dioxane. 
After 1 hr incubation, NMM (0.6 mg) was added to the solution. Control substrates were 
prepared by keeping amino-PEG2k-thiol-modified SPR gold sensor immersed in dioxane 
overnight. All substrates were washed thrice with dioxane and methanol and dried under 
nitrogen. An E2-modified SPR sensor was placed in the SPR cell compartment. PBS (10 mM, 
pH~7.4) was passed through the cell until the baseline was stable. Thereafter, solutions of 
increasing ER-α concentration (1 to 100 nM) in PBS were introduced sequentially in the 
sample cell with a flow rate of 10 µL min-1. At the end of the treatment, the sample cell was 
flushed with the PBS buffer to remove excess ER-α. Adsorption of ER-α onto amino-PEG2k 
coated SPR sensor surface was evaluated under the same conditions. All measurements were 
performed at room temperature. The SPR instrument records the angle of minimum resonance 
(m). The surface coverage () was calculated using the Fresnel model reported previously 
using the Winspall software (version 3.02) using the following parameters [36]: the real and 
imaginary parts of the dielectric constant, ’ and ”, respectively, for each surface plasmon-
supporting metal layer at the wavelength of excitation 780 nm were ’ = 3.1002, ” = 0 for the 
sapphire prism, ’ = -2.0185, ” = 35.755 for the Cr adhesion layer,  ’ = -23.886, ” = 1.7435 
for the Au layer,  ’ = 1.8824, ” = 0 for the film tested, and ’ = 1.7814, ” = 0 for water.[37]  
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            Quartz crystal microbalances with dissipation (QCM-D) studies were carried out with 
an E4 system (Biolin, Sweden). Gold-coated 5-MHz AT-cut quartz crystals (Quartz Pro, 
Sweden) were cleaned with a piranha solution (WARNING: see above.). The E2 
functionalization as well as ER-α adsorption studies were using the same protocol as depicted 
in SPR part. The QCM-D results are presented as the normalized frequency shift recorded for 
the fifth overtone (25 MHz).  
            The QCM-D data were analyzed with the QTools 3.0 software (Biolin, Sweden) based 
on the Sauerbrey equation that is widely used for modeling thin protein  films.
[38]
 In this model, 
the frequency shift (Δf) is related linearly to the total adsorbed mass, expressed as surface 
coverage (), as shown in the following equation (1): 
 = − ஼�௡                                                                                                   (1) 
            where C is a constant based on the physical properties of the quartz crystal (C = 0.177 
mg m
-2
 Hz
-1
) and n represents the overtone number (n = 1, 3, ...). The buffer density and 
viscosity were set at 1000 g dm
-3
 and 1 mPa s
-1
, respectively. 
4.4.5 Fabrication and modification of micropatterned surfaces  
            Glass coverslips (3.0 x 3.0 cm, 0.13–0.17 mm thick, Matsunami) were sonicated three 
times in acetone, rinsed twice with isopropanol, and dried under a flow of nitrogen.  They 
were treated by O2-plasma asher (PB600, Yamato Scientific) under a stream of O2 at 300 W 
for 3 mins. A hexamethyldisilazane (Tokyo Ohka Kogyo, Japan) adhesion layer was deposited 
on the cleaned substrates by spin-coating. Subsequently, the photoresist (OFPR-800 LB 54 cp, 
Tokyo Ohka Kogyo, Japan) was spin-coated on the modified substrate to achieve a thin 
uniform layer. The substrates were baked at 90 oC for 3 mins. A second photoresist (AZ 5214-
E, Clariant, Switzerland) was spin-coated on the substrates followed by a 6 mins bake at 90 
oC. The substrates were irradiated through a photomask using the g-and i-lines of the UV light 
emitted by a mercury lamp (18 mW/cm2 for 6 secs). After irradiation, the substrates were 
baked at 120 oC for 30 secs. They were immersed in a NMD-3 developer solution (Tokyo 
Ohka Kogyo, Japan), gently agitated for 60 secs, rinsed with water, and dried with a flow of 
nitrogen. The dried substrates were descumed with the plasma asher for 30 secs. A 5-nm 
titanium layer and a 20 nm-gold layer were vacuum-deposited consecutively on the substrates 
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using an E-beam evaporator. The coated substrates were immersed in AZ remover 100 
(Clariant, Switzerland) for several hrs. They were rinsed with isopropanol and dried with 
nitrogen. They were cut to size with an automatic dicing saw (DAD3220, Disco, Japan) and 
kept in a desiccator until use. SEM (scanning electron microscopy) images of the patterned 
substrates were recorded with a SU8230 field emission SEM (Hitachi, Japan) at an 
accelerating voltage of 1 kV.  
            Prior to functionalization, the micropatterned surfaces were washed 5 times with 
acetone and sonicated in acetone for 5 mins. The same procedure was repeated with 2-
propanol and hexane.  Finally, the substrates were dried with nitrogen, cleaned with the O2-
plasma asher for 5 mins and placed in an UV-ozone cleaner for 1 hr to activate the silica areas 
of the patterned surfaces, which, subsequently, were functionalized with cRGD on the glass 
areas as described above and, afterwards, E2 was immobilized on the gold islands, as 
described above.  
4.4.6 Detection of ERK phosphorylation by cell ELISA 
            The functionalized micropatterned surfaces were placed on a glass bottomed 35-mm 
dish (MatTek, USA). Starved MCF7 cells were harvested with 5 mM EDTA/PBS for 15 mins 
at 37 ˚C and seeded on the micropatterned surfaces at 3.1 x105 cells/cm2 in a serum-free 
DMEM/f12 medium. After incubation at 37 ˚C for 1 hr, cells were fixed overnight at 4 ˚C with 
4% paraformaldehyde in phosphate buffer (Wako, Japan). The surfaces were placed in a 96-
wells plate (Thermo, USA) and the cells were permeabilized with 0.5% Triton X-100 in PBS 
for 15 mins at room temperature. The wells were blocked with 2% BSA/PBS for 1 hr after 
washing each well with PBS. For the detection of ERK phosphorylation, the cells were reacted 
with mouse immunoglobulin G (IgG) for phospho-ERK1/2 (T202/Y204) for 2 hrs, followed 
by washing with PBS for 4 times. Subsequently, the cells were treated with anti-mouse IgG 
alkaline phosphatase conjugate (Sigma Aldrich, USA) for 1 hr at room temperature and 
washed in the same way. The amount of phosphorylated ERK was detected by adding p-
nitrophenyl phosphate (Sigma Aldrich) in a Tris/HCl buffer (1 M, pH~ 9.8) containing 0.5 mM 
MgCl2, and the optical density (OD) at 405 nm was recorded using a microplate reader 
(BioRad, model 680, USA). Data were compared for significance of differences using the 
student’s t-test (P < 0.05).  
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4.4.7 MCF-7 cell proliferation assay 
            Functionalized micropatterned surfaces were placed in a 96-well plate and conditioned 
cells were seeded on them at a concentration of 5,000 cells/well. The cells were incubated for 
2 days at 37 ˚C, 5% CO2. Cell proliferation was evaluated using a CellTiter 96 AQueous Non-
Radioactive Cell Proliferation Assay (Promega, USA) according to the protocol supplied by 
the manufacturer. The optical density at 490 nm was measured with the plate reader. Data were 
compared for significance of differences using the student’s t-test. 
4.5 Results and discussions 
4.5.1 Design of micropatterned substrates 
            Figure 4.1 depicts the interactions at play between a cell and the patterned substrate 
(A: side view and B: top view). Integrins on the plasma membrane of the cell (blue rectangles), 
responsible for cell adhesion, interact with cRGD (blue ovals), a glass-linked peptide with 
Arg-Gly-Asp sequences known to promote cell adhesion, while mERs (red rectangles) on the 
plasma membrane interacts with E2 (light blue triangles) bound to the gold islands (yellow 
rectangles in A or yellow discs in B). A scanning electron micrograph (SEM) of the 
micropatterned substrate prior to chemical modification is presented in Figure 4.1C. It consists 
of gold dots, with a diameter of 2 ȝm, arrayed on glass with a 12-ȝm pitch.  Micropatterns 
with different gold dot arrangements were available (see Figure SI.4.1). The chemical 
functionality of the substrates was introduced in two steps. First, the glass sections were 
modified by a sequence of reactions (Figure 4.1D) involving, treatment of the glass with a 1:1 
w:w mixture of PEGylated-triethoxysilane and NHS-PEG2k-trimethoxysilane, followed by 
introduction of cRGD by reaction with NHS-activated carboxylic acid groups tethered to the 
glass.  Subsequently, the gold disks were modified by treatment with amino-PEG2k-thiol, 
followed by coupling of 17α-ethinylestradiol benzoic acid (E2) to the tethered amines (Figure 
4.1E). Special care was taken to minimize possible cross-reactions between the reagents used 
to treat the glass and gold regions. For example, excess NHS groups in the glass regions were 
quenched by addition of excess aminoethanol. In addition, E2 was incubated with the coupling 
agents, CDMT and NMM, prior to addition to the amino-PEG2k-thiol-functionalized 
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patterned substrates. All other aspects of the functionalized were identical to the treatments 
validated on either glass or gold substrates and described in detail in the following sections. 
 
Figure 4.1 (A and B) Schematic representations of the micropatterned substrate employed. 
cRGD (for the interaction with integrin) and E2 (for the interaction with mER) are co-
immobilized onto a PEGylated micropatterned surface to ensure cell adhesion and E2 
presentation to the cell membrane. (C) SEM image of the micropatterned surface consisting 
of gold circular regions (diameter: 2 ȝm) arrayed with a 12-ȝm pitch (scale bar: 5 ȝm); and 
chemical sequences performed on glass surfaces (D) and on gold surfaces (E).  
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4.5.2 Immobilization of cRGD onto glass substrates 
            Model glass substrates (coverslips) coated with a mixture of PEG (2 kDa) and NHS-
terminated PEG (2 kDa) chains were treated with either lRGD or cRGD, two peptides known 
to promote cell adhesion. A third glass substrate, coated with PEG alone, served as control. 
The substrates were incubated with MCF-7 cells (20,000 cells/mL) for 1 hr and observed by 
phase contrast microscopy, revealed that both lRGD and cRGD promote cell adhesion, cRGD 
being more effective than lRGD.  Micrographs of control, lRGD-coated, and cRGD substrates 
after a 1 hr-incubation with MCF-7 cells are shown in Figure 4.2 (A-C) together with a 
quantitative analysis of the number of cells attached on each substrate Figure 4.2D. This 
experiment indicates that cRGD, significantly enhances the number of adhered cells (P < 0.05) 
whereas lRGD only marginally enhances cell adhesion, compared to the control substrate. As 
reported earlier, the conformation of cRGD is more amenable to interaction with integrins, 
compared to lRGD.[39] In view of this result, the experiments described below were carried out 
exclusively with cRGD-modified glass surfaces.  
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Figure 4.2 Cyclic RGD (cRGD) functionalized glass substrate enhanced MCF-7 cell adhesion. 
(A) Optical images of MCF-7 cell onto the PEGylated glass substrate after 1 hour incubation 
at 37 ˚C, 5% CO2. (B) Optical images of MCF-7 cell onto the linear RGD functionalized glass 
substrate after 1 hour incubation at 37 ˚C, 5% CO2. (C) Optical images of MCF-7 cell onto the 
cRGD functionalized glass substrate after 1 hour incubation at 37 ˚C, 5% CO2. (D) 
Quantification analysis of cell numbers. All the data are expressed as mean ±S.E. of triplicate 
determinations. P<0.05 is considered as the significantly statistical difference. 
4.5.3 XPS characterization of E2-PEG2k modified gold surfaces. 
            Having established a robust protocol for the fabrication of glass-supported cell-
adhesive surfaces, we turned our attention to the immobilization of E2 on gold-coated 
substrates, following the protocol depicted in Figure 4.1E. An amino-functionalized PEG thin 
film was deposited on a gold substrate using amino-PEG2k-thiol. E2 was linked to the 
substrate via an amide linkage of the 17α-ethinylestradiol-benzoic acid to the amine groups of 
amino-PEG2k-thiol. The success of the chemical modification was evaluated by XPS analysis 
of the substrates after each chemical modification. XPS survey scans of bare gold, amino-
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PEG2k-coated gold and E2-modified PEG-coated gold are presented in Figure SI.4.2. The 
XPS scan of amino-PEG2k-thiol coated gold presents a signal at 285 eV, attributed to the 1s 
carbon atoms of the PEG chain.
[40]
 This signal is enhanced after modification of the surface 
with E2, as evidenced by increases in the C/Au ratio from 5.53 to 6.84 as well as the C/O ratio, 
from 3.93 to 4.39. Considering the fact that the theoretical C/O for the PEG chain is ~2.02 and 
C/O for E2 is ~8.33, the increase in the C/O ratio represents successful conjugation of E2 to 
the PEG. 
4.5.4 SPR evaluation of the interaction of ER-α with E2-modified gold 
substrates 
            ER-α solutions ranging in concentration from 1 to 100 nM were passed sequentially 
over E2-coated substrates placed in the flow cell of an SPR system. An example of the SPR 
real-time mass adsorption at each ER-α concentration is shown in Figure 4.3A. The SPR 
signal yields information on the association of ER-α to the E2-modified surface. The injection 
of each ER-α solution triggered a significant increase of the SPR minimum resonance angle, 
m. After rinsing the SPR cell with buffer, the m value was at ~0.0556 o. The black trace in 
Figure 4.3A corresponds to the injection of ER-α solutions of increasing concentration in the 
SPR flow ell fitted with an amino-PEGylated surface devoid of E2. In this case, the m value 
after the final rinse was nearly identical to the initial m. The ER-α surface coverage values on 
the E2-modified surface and on the control surface, calculated from the corresponding m 
values, are plotted as a function of the  ER-α solution concentration in Figure 4.3B (red and 
black triangles).  Also shown in Figure 4.3B are the values recorded after the final rinse (red 
and black circles). The final ER-α surface coverage of the E2-modifed surface (~120 ±1.6 
ng/cm
2
) of the same order as data reported previously for the binding of ER-α to E2 
immobilized to chitosan phosphorylcholine films
[41]
 and on carboxymethylated dextran 
gels.
[42]
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Figure 4.3 (A) SPR traces corresponding to the addition of ER-α solutions onto the E2-
modified PEGylated gold substrate (red) and a control PEGylated gold substrate (black); 
temperature: 25oC. (B) ER-α coverage (ng/cm2) as a function of ER-α concentration of the 
solution injected  on the E2-modified PEGylated gold substrate (red symbols) and on the 
control PEGylated gold substrate (black symbols); the circles are the surface coverage values 
after rinsing the substrates with buffer.  
 
(A)
(B)
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4.5.5 QCM-D studies of the adsorption of ER-α on gold substrates modified 
with E2-PEG2k 
            The QCM-D experiments described next were performed with gold-coated quartz 
crystals modified ex-situ with E2-PEG or with amino-PEG (control) according to the sequence 
presented in Figure 4.1E. The substrates were placed in the QCM-D cell and conditioned in 
PBS buffer. Examples of real-time ER-α adsorption scans are shown in Figure 4.4A, where the 
red traces correspond to experiments carried out with E2-modified substrates and the black 
traces are scans of control measurements done with amino-PEG films. Sequential addition of 
solutions of increasing ER-α concentration (1 nM to 100 nM) was performed similarly to the 
SPR experiment. Finally, buffer was passed over the films to remove loosely bound protein.  
The ER-α binding kinetics monitored by QCM-D are reflected by changes versus time in 
frequency (Δf5, 5th overtone) (Figure 4.4A, top) and in dissipation (ΔD5) (Figure 4.4A, bottom). 
Changes in the frequency report on the mass of the protein adsorbed to the surface of the 
vibrating crystal including the water hydrodynamically coupled to the protein. In the case of 
thin rigid films, the mass uptake is related to the frequency shift by the Sauerbrey equation 
(see experimental section). This equation was employed here as it was shown to be applicable 
to thin protein films.
[38]
 The added mass values of the E2-modified and amino-PEG-modified 
as a function of the injected ER-α solution concentration are plotted in Figure 4.4B. For both 
films, the bound mass increases as a function of the ER-α solution concentration. The values 
recorded after the buffer rinse were ~161.4 ng/cm
2  
and ~ 20.3 ng/cm
2
, respectively, for E2-
PEG films and amino-PEG films. By comparing the QCM-D derived mass to the SPR data, it 
is possible to determine the water content of the protein layer.  The w% (26%) of water is 
small which may indicate that the protein forms a rigid layer on the surface.
[43]
 
            The dissipation factor (D) reveals the viscous losses induced by the deposited mass and 
carries information on the viscoelasticity of the adsorbed layer, reflecting the conformation 
and binding strength of the adsorbed protein layer.
[44, 45]
 Plots of ΔD as a function of Δf  shown 
in Figure 4.4C, reflect the dissipation changes depending on surface mass
[45]
 and provide 
information on the conformational changes of ER-α during the adsorption process.[46] The ΔD-
Δf correlation shows distinctive viscoelastic features on both the E2 modified surface and the 
control surface. For the control surface, it would suggest that non-specific ER-α adsorption 
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generate higher internal molecule friction, leading to the energy loss in oscillation. However, 
the slope of the ΔD-Δf plot is smaller in the case of the E2-functionalized surface, suggesting 
the formation of a dehydrated and tightly-bound protein layer.
[31]
  
 
Figure 4.4  (A) Frequency (Δf) and dissipation (ΔD) shifts as a function of the concentration of 
the ER-α solution injected in the QCM-D cell compartment fitted an E2-modified substrate 
(red trace) and the control substrate (black trace); (B) ER-α coverage (ng/cm2) as a function of 
ER-α concentration of the solution injected  on the E2-modified PEGylated gold substrate (red 
symbols) and on the control PEGylated gold substrate (black symbols); the circles are the 
surface coverage values after rinsing the substrates with buffer; (C) ΔD-Δf plots for the ER-α 
adsorption onto the E2-modified surface (red trace) and the control surface (black trace). 
Different concentrations are also indicated by different colors for amino-PEG substrate and 
E2-PEG substrate.  
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4.5.6 Biological activity of E2-modified micropatterned substrates 
            Having established robust protocols to modify glass surfaces, to render them cell-
adhesive, and to tether E2 to gold substrates while preserving the interaction of ER-α with E2, 
we functionalized micropatterned substrates as described in experimental section and depicted 
in Figure 4.1. We confirmed that micropatterned surfaces with gold islands bearing amino-
PEG2k-thiol and those with E2-bound islands exhibit the same cell adhesiveness as surfaces 
without E2, as observed by comparing Figures 4.5A and 4.5B. The MCF-7 cells exhibited 
similar adhesion to both patterned substrates, indicating that the activity of the cRGD ligands 
was not affected significantly by the sequential functionalization of the gold islands. It should 
be noted that the separation distance (~ 10 m) between the gold islands is smaller than the 
size of single MCF-7 cells, as seen in the enlarged micrograph shown in Figure 4.5C, where 
gold dots are visible in areas devoid of cells. Under these conditions, most cells attached to a 
micropatterned surface should be able to interact with the surface-immobilized E2 ligands. 
Cells were harvested with EDTA, rather than trypsin, in order to ensure that membrane 
proteins remain intact (undigested), favoring rapid cell adhesion.  Therefore it should be 
possible to monitor cellular responses within the first hour following cell contact with the 
substrate. 
            Next, we analyzed by cell ELISA of the ERK phosphorylation activation level upon 
cellular adhesion to the substrates. As observed in Figure 4.5D, the ERK phosphorylation level 
was significantly higher in cells grown on E2-functionalized substrates, compared to cells on 
control (NH2) substrates: 0.563 ± 0.056 vs. 0.475 ± 0.036,  or 18.7%, P < 0.05. The difference 
in ERK phosphorylation levels is small, but it is of reasonable value knowing that even 
“soluble E2” at a concentration of 10-6 M, which is significantly higher than physiological 
concentrations, evoked only 27% increment, under the experimental conditions employed here 
(Figure SI.4.3). Moreover, similar ratios of ERK phosphorylation in E2-conjugates versus to 
free E2 (10% vs. 20%) were reported previously in a study of the response of clonal rat 
prolactinoma cell lines to E2-peroxidase conjugates.
[47]
   
 We also investigated whether surface-immobilized E2 stimulates the proliferation of 
MCF-7 cells. As seen in Figure 4.5E, the growth of MCF-7 cells on E2-functionalized 
substrates was approximately the same as in the case of control substrates. This observation is 
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important, as it suggests strongly that the genomic signaling pathway is not stimulated by 
surface-immobilized E2. Taken together, these initial results indicate that E2-functionalized 
micropatterned substrates described here may be extremely useful tools for systematic studies 
of the estrogen non-genomic pathway and its selective activation.  
 Recently, an estrogen-dendrimer conjugate (EDC) was reported to modulate 
selectively non-genomic estrogen response. However, the observation that EDC was localized 
in the cytoplasm raises questions on the actual nature of its interaction with ER-α and 
transportation mechanisms.
[20]
 Our demonstration that estrogen immobilized micropatterned 
surfaces are able to evoke estrogenic non-genomic pathways implies that the E2-conjugates 
initiate the estrogenic activity via the plasma membrane ER and precludes the possibility of 
membrane ER transportation to a cytoplasmic site for downstream signaling. Thus, this feature 
of E2-immobilized micropatterned substrates is critical as it isolates plasma membrane 
associated non-genomic effect efficiently. The micropatterned surfaces can be modified 
readily with molecules other than E2  for use in selective hormonal drug screening, a subject 
of intensive current research.
[48]
 
 
Figure 4.5 Cellular response to E2-functionalized micropatterned substrates. Optical 
micrographs of starved MCF-7 cells seeded on micropatterned substrates which glass areas 
functionalized with cRGD and gold dots  modified with NH2 (A) or E2 (B)  incubated for 1 hr 
at 37 ˚C, 5% CO2; scale bars: 100 µm; the micrograph (C) is a magnified view of (B); scale 
bar: 25 m; the arrows point to gold dots. (D) ERK phosphorylation of MCF-7 cells on each 
substrate; bars: mean ± S.E. of triplicate determinations. (E) MCF-7 cell proliferation on 
amino- or E2-immobilized micropatterned substrates after a 2-day incubation. 
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4.6 Conclusions 
            The objective of this study was to prepare E2-immobilized micropatterned surfaces 
and to demonstrate their use in studies of the non-genomic effects of E2 and, eventually, other 
steroids. Studies by SPR and QCM-D confirmed the successful immobilization of estrogen on 
the selected substrates and the abilities of tethered E2 to interact with ER-α. Furthermore, 
using a cell ELISA study, it was possible to detect the stimulation of a key component of the 
estrogenic non-genomic signal pathway, namely ERK phosphorylation, in MCF-7 cells placed 
in contact with   E2-modified micropatterned substrates. Future studies will focus on the use of 
estrogen patterned surfaces to trigger faster signal transduction pathways associated to the 
non-genomic effect and to understand the crosstalk within these pathways. A detailed pathway 
profiling in response to biomedical applications of estrogen non-genomic effects, such as 
reproduction or neuroprotection, will be the next challenge, to be addressed using the tool 
described in this report.  
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4.9 Appendix C. Supporting information  
 
 
Preparation of micropatterned substrates with different gold dots densities 
 
 
 
Figure SI.4.1 SEM images of micropatterned surfaces in different densities. Left: diameter in 
2-ȝm gold circular regions were arrayed in 6-ȝm pitches; Right: diameter in 2-ȝm gold 
circular regions were arrayed in 4-ȝm pitches. 
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XPS analysis of E2-immobilized gold surface 
 
 
Figure SI.4.2 XPS analysis of E2-immobilized gold surface (bare gold: black trace; NH2-
PEG-thiol surface: red trace; E2 immobilized NH2-PEG-thiol surface: blue trace). E2 
immobilization onto amino-PEG-thiol modified gold surface is validated by comparing the 
ratio of C/Au and C/O as depicted in the results section. After the E2 immobilization, both of 
the ratio of C/Au increased from 5.53 to 6.84 and the ratio of C/O increased from 3.93 to 4.39, 
suggesting the success of E2 immobilization on the topmost layer of the surface. 
 
Cell ELISA study of ERK phosphorylation by soluble E2 
            To look at the ability of free E2 in activation of non-genomic pathways, cell ELISA 
experiments were performed in a similar fashion to those described in the text. We focused on 
the very early stage of ERK activation (5 min), as MCF-7 cells are known to exhibit a 
transient response to soluble E2 due to the following rapid desensitization processes.[1, 2] Cells 
were seeded in a plastic 96-well plate at 5 x 104 cells/well and serum-starved for 4 hrs. Just 
before E2 administration, DMSO stock solutions of E2 were diluted in the serum free medium 
and then added to each well. The final E2 concentrations were 0, 10-12, 10-9, 10-6 and 10-5 M, 
keeping the DMSO solution constant (0.1%). After incubating for 10 min, the cells were fixed 
with 4% paraformaldehyde and the cells were processed to the same procedure as described in 
the experimental section of the main text. The cellular responses were normalized for that 
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without E2. They exhibit concentration-dependent increase in ERK phosphorylation with 
saturation around 10-6 M E2. It should be noted that physiological E2 concentration is around 
10-9 M based on literature.[3] 
 
 
 
Figure SI.4.3 ERK phosphorylation by soluble E2. Starved MCF-7 cells were seed in plastic a 
96-well plate. The cells were stimulated in the corresponding concentrations of E2 dissolved 
in DMSO and incubated for 5 min before fixation. ERK phosphorylation was quantified with 
cell-based ELISA. The values were normalized with that without E2 (E2 concentration, 0). 
Bars mean±S.E. of triplicate determinations.  
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In cardiovascular medicine, E2 binds to membrane ERs, induces acute non-genomic 
effect and thereafter possesses endothelium-dependent protective effects.
[1]
 However, E2-
mediated non-genomic events happen in a very transient time scale and hence are difficult to 
detect experimentally.
[2]
 In attempting to maintain the activation of  membrane ERs in a long-
term frame, some efforts have been made via using E2-conjugates, such as E2-BSA or E2-
dendrimer, those can retain staying in the extra-nucleus localization.
[3]
 But they are arguably 
recognized as stable systems due to the discrepancies of their in vitro localization and in vivo 
distributions.
[4]
 Moreover, E2-conjugates can easily form aggregates because of the 
hydrophobic nature of E2, which also leads to difficulties in inducing biological responses. To 
solve these issues, surface-tethered E2 was prepared by both bottom-up and top-down 
approaches in this project. By bottom-up approach, E2 was tethered onto a phosphorylcholine 
grafted chitosan (CH-PC) polymer backbone and formulated to self-assembled functional film. 
The physical chemistry properties and in vitro cellular responses of CH-PC-E2 and CH-PC 
polymer films were separately investigated. Based on these studies, such E2 tethered CH-PC 
polymeric platform would be beneficial for protection of the cardiovascular system. In order to 
further elucidate the biological mechanisms of surface-tethered E2, E2 was functionalized 
onto micropatterned substrate based biosensor, which were prepared with a photolithography 
by top-down approach. The relevant cell signaling study and cell proliferation study showed 
that E2-functionalized micropatterned biosensors can efficiently isolate non-genomic signaling 
pathways from genomic signaling pathways without inducing cell internalization. This E2-
biosensor-based technology controlled exposure concentration and time of surface-tethered E2 
to cells in a well-defined manner and enabled us to investigate the fundamental steroid biology 
in depth.  
5.1 Physical and biological properties of CH-PC polymer thin 
films 
As an appropriate polymer backbone for E2 surface tetheration, chitosan substituted 
with various degrees of phosphorylcholine (15, 25, 40 mol% to per glucosamine unit) was 
selected in view of its excellent mechanical property, cationic nature for the cell adhesion, and 
non-fouling characters. Before E2 tetheration, an independent study related to the physical and 
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biological properties of CH-PC polymer solution and thin films was firstly systematically 
performed, from a polymer perspective. In solution phase, CH-PC polymers contain polymer 
chains interconnected by hydrogen bonds and ionic interactions, so they form aggregates. By 
increasing the incorporated amount of PC groups (from 15 to 40 mol %), CH-PC polymers in 
solution self-assembled into more compacted aggregates due to inter- or intra-particle ion 
pairing. After depositing CH-PC solutions onto solid supporting substrate, they formed films 
with similar mechanical properties. 
            In order to confirm the non-fouling character of CH-PC film, the interactions between 
non-specific proteins/cells and CH-PC films incorporated with different PC levels were 
investigated. Generally, fibrinogen adsorption on CH-PC films formulated in situ significantly 
decreased upon increasing the PC incorporated level from 15% to 40%. This result was in 
accordance well with the subsequent ER-α binding study that only very small portion of ER-α 
non-specific adsorption occurs in the CH-PC films. However, we need to find a moderate level 
of PC incorporation in the CH backbone in terms of balancing its solubility in physiological 
conditions and non-fouling characters. In a previous study, Tardif et al., suggested that PC-
substituted chitosans was capable of supporting the survival and amplification of EPCs and 
was readily soluble under physiological conditions if the level of PC incorporation equals to 
~20 %.[5] As a result, a CH-PC20 polymer conjugate will be used to the subsequent E2 
tetheration studies. Besides, it is also expected that other zwitterionic groups, such as 
sulfobetaine or carboxylbetaine, could be linked to chitosan backbone with the similar 
chemical reactions as phosphorylcholine. The physiochemical properties among those 
chitosan-zwitterionic conjugates could be further studied and discussed in the comparison of 
CH-PC conjugates. 
            Meng et al. reported that a CH-PC synthesized by an heterogeneous process formed 
substrates adhesive towards HUVECs even though the PC content of the polymer was high (~ 
0.60 wt. % phosphorus).[6] The CH-PC samples described in my project were obtained under 
homogeneous conditions that favor random distribution of the PC groups along the CH chain. 
They are expected to present a more homogeneous PC distribution on the film/water interface, 
compared to the films studied by Meng et al. In addition, HUVECs formed three dimensional 
spheroids on drop-casted CH-PC films when the PC incorporated level exceeds 25% due to 
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their non-adhesive properties. The size of the cellular spheroids increased dependent on PC 
incorporated levels and culturing time. Compared to the traditional grafts containing a two-
dimensional cell monolayer, three-dimensional HUVEC spheroid culture in CH-PC coated 
substrates possibly results in a higher cell survival rate and enhanced angiogenesis post-
grafting, which mimics the in vivo physiological conditions more realistically.[7, 8] To sum up, 
our study demonstrates that CH-PC films form a promising platform for 3D-cellular grafts to 
promote vascular healing in future in-vivo applications.  
            In the future, more in vitro and in vivo biological studies could be performed on the 
CH-PC coated substrates to investigate their possible roles in tissue engineering. For example, 
“Live/Dead” long-term endothelial cell viability and proliferation tests could be carried out by 
Alarmar blue/Trypan blue staining assay to determine the cell survival rate cultured in the CH-
PC coated substrates.[9]  
5.2 Synthesis, characterization and biological studies of CH-PC-E2 
self-assembled films in the cardiovascular regenerative medicine 
            In this project, an activated E2 ligand (E2-benzoic acid) was covalently tethered to the 
CH-PC backbone via an amide linker as a prodrug strategy. The substitution degree of E2 per 
glucosamine unit is ~5%, while the PC content was ~20% as introduced in the previous 
section. It was shown that the mechanical properties and cellular responses of CH-PC-E2 
samples are greatly associated with various formulation methods. CH-PC-E2 formed 
hydrogel-like thin films by self-assembly bottom-up approach and significantly stimulated NO 
production in endothelial cells by a diaminofluorescein-FM diacetate (DAF-FM) imaging 
study, indicating its protective effect in cardiovascular system. 
            Polymer conjugates based prodrug strategy were attracted interest due to its unique 
therapeutic efficacy, e.g. enhanced bioavailability and cell specificity, in cardiovascular 
medicine.[10-12] In a previous study, an E2 derivative, estradiol-3-benzoate (EB), was attached 
to copolymer to poly(α,β-(N-2-hydroxyethyl-DL-aspartamide))-poly(α,β-(N-2-aminoethyl-
DLaspartamide)) copolymer (PAHA) PAHA as a prodrug in order to enhance its solubility 
and stability.[13] But unfortunately, the clinical efficacy of PAHA-EB was not addressed yet.[14] 
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Previously, E2-dendrimer conjugates showed in vivo beneficial vascular protection effects 
without inducing proliferation of breast cancer cells, which is associated with its non-genomic 
behavior.[15] In this study, the E2-dendrimer conjugates significantly increase around ~2 times 
vs. free E2 (conc. 10–8 M) ~1.7 times of the expression of endothelial nitric oxide synthase 
(eNOS) level, which is critical in the regulation of the NO. Moreover, EDC didn’t lead MCF-7 
breast cancer cell proliferation in vivo while free E2 induced ~3 times significant higher 
growth of tumor weight. In our present CH-PC-E2 films, NO production was significantly 
increased (~1.65 times higher NO production) compared to CH-PC control film, which is 
accordance well with EDC studies. However, due to the thin film formulation of our CH-PC-
E2 sample, it is impossible to directly determine its potential risk of MCF-7 breast cancer cells 
proliferations. The reason is because that MCF-7 cells form spheroid structures on CH-PC 
substrates (explained in the previous chapter), leading the cell counting experiment difficult to 
be performed. As a result, a selected surface tethered E2-based cancer cell proliferation study 
could be developed to evaluate its risk in clinical therapy. More importantly, the E2 
distribution onto the CH-PC polymer backbone was random. As a result, it is highly required 
that develop a biosensor to control the concentration and time of surface-tethered E2 
presentation to cells in order to elucidate more details about biological mechanisms. We will 
further to discriminate non-genomic and genomic action of surface-tethered E2 in the 
subsequent E2-functinonalized micropatterned biosensor study by controlling MCF-7 cell 
attachment and E2 densities in a well defined manner. Finally, single cell based non-genomic 
effect studies could be performed by using E2-functionalized micropatterned substrates that 
confine the cells to restricted spaces.[16]   
            In the future, in vitro and in vivo studies could be performed to determine whether CH-
PC-E2 hydrogel stimulates endothelial cell growth and promotes blood vessel formation. In 
this sense, CH-PC-E2 hydrogels would possibly induce the regeneration of 
vasculature/endothelium and engage in angiogenesis/neovasculogenesis processes, which 
hence decrease the progression of cardiovascular disease, such as atherosclerosis.  
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5.3 E2-tethered micropatterned substrates selectively activate non-
genomic signal pathways  
            In this section, the activated E2 ligand (E2-benzoic acid, the same as the one used for 
CH-PC-E2 preparation) and a cell-adhesive ligand (cyclic RGD) were covalently co-
immobilized onto a micropatterned substrate to construct a biosensor for E2 non-genomic 
effect study. Recently, the report on the cytoplasimic localization of estrogen-dendrimer 
conjugate (EDC) raised questions on its interaction and transportation mechanisms.[17]  Our 
results on the ability of the E2-tethered micropatterned surface to evoke estrogenic non-
genomic pathways clearly demonstrates that the reaction of E2-conjugates does initiate at the 
cell membrane ER and meanwhile precluding the necessity of membrane ER transportation 
(even after surface immobilized E2/ER binding) to the cytoplasm site for the downstream 
signaling. 
            In the current study, the ERK phosphorylation level was more significantly increased 
(18.7%) on the E2-functionalized micropatterned substrates than the control surfaces after 1 
hour of incubation. These data are promising since free E2 alone induced ERK activity usually 
occurs within 15 minutes.[18]  In our case, the increment can be maintained up for to 1 hour 
which indicates that our E2-functionalized micropatterned substrate can stimulate non-
genomic effects constantly. However, the difference in ERK phosphorylation levels is not so 
big, but it is reasonable considering the fact that even soluble E2 (at 10-6 M, sufficiently higher 
than physiological concentrations) can evoke only 27% increment in our experimental 
conditions. Moreover, similar smaller ERK phosphorylation in E2-conjugates compared to 
free E2 (10% vs. 20%) has been reported previously in the study of the response of clonal rat 
prolactinoma cell lines to E2-peroxidase.[19] In the upcoming work, the ERK activation at 
various points in time should be determined to obtain a time-dependent curve. In the present 
study, we found that MCF-7 cells didn’t adhere well on the E2-functionalized micropatterned 
substrates in a longer time incubation (>1 hour). So how to optimize cell culture conditions, 
e.g. to control cRGD densities or geometries of gold regions, will be the next challenge.  
            Further, a spatial and temporal dynamic control of E2 exposure to cells in E2-
functionalized micropatterned substrates could be implemented to enhance the sensitivity of 
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our biosensor. For spatial control, different densities of gold circular regions in a 2-ȝm 
diameter were prepared with the pitches of 4-ȝm, 6-ȝm, and 12-ȝm, respectively. The 
densities of golden circular regions with a 12-ȝm pitch were used for the current cellular 
study. In the future, other densities of golden circular regions should be investigated and 
compared by optimizing cell culture conditions. In addition, cells can contact E2 in a gradient 
concentration and the relationship of cellular responses to E2 concentration can be achieved. 
In order to temporal control, one idea is to co-immobilize photo-cleavable PEG (Mw = 12 
kDa)
[20]
 with E2 together onto the gold surface. Photocleavable PEG is capable of preventing 
the exposure of adjacent ligands to the cell surface.
[21]
 Hence the time of E2 exposure to cells 
can be precisely regulated by controlling the time of photo-irradiation. 
            Furthermore, it is widely accepted that the exact cellular location of ER is still 
enigmatic.[22] Another studies reported that E2-induced ERK/MAPK activation was mediated 
through a G protein-coupled receptor, GPR30.[23] Recent studies have also implicated that 
GPR30, a G protein-coupled seven transmembrane receptor target, functions as a plausible 
candidate for mediating membrane initiated steroid signaling in breast cancer.[24] But the 
assumption that GPR30 mediated E2 non-genomic pathway continues to be disputed.[25] 
Therefore, GPR30 signaling was not analyzed by surface E2-tethered micropatterned 
substrates in present study. However, some additional experiments could be performed to 
examine whether the activation of ERK is induced due to the direct interaction between E2 
and ER or due to the other possible factors’ contributions. 
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6.1 Conclusions 
            The objective of research described in this thesis aims to develop surface-tethered E2 
based biomaterials and biosensors for cardiovascular regenerative medicine through the 
investigation of E2 non-genomic actions. To begin with, E2 was grafted onto the chitosan 
phosphorylcholine (CH-PC) polymer. The characterization and cellular studies of the CH-PC 
functional films were performed. It was demonstrated that the fabrication method significantly 
influences mechanical properties, depth-dependent composition, and biological responses of 
the films. A selected method was developed by grafting E2 to the CH-PC backbone for the 
preparation of self-assembled interfaces via a bottom-up approach. The rehydrated CH-PC-E2 
film could maintain E2 exposure to the topmost layer of the interfaces due to its hydrophobic 
nature. Throughout QCM-D measurements, hydrated CH-PC-E2 films possess similar visco-
elastic properties as hydrogels. By investigating its effect in the process of NO production, the 
CH-PC-E2 hydrogel films could be considered as new coating materials for the cardiovascular 
contacting devices. In another aspect, E2 was covalently immobilized onto the PEG-
functionalized micropatterned substrate, which is fabricated by aligning gold circular regions 
onto the glass substrate via a photolithography. A selected non-genomic ERK signal pathway 
was successfully activated in the E2-functionalized micropatterned substrates coupled by cell 
ELISA technique. Moreover, E2-functionalized micropatterned substrate didn’t induce breast 
cancer (MCF-7) cell proliferation, suggesting that it had no influence to genomic effect. 
Compared to previous E2 conjugated dendrimer study, E2-functionalized micropatterned 
substrate can provide new insights to specifically interact with plasma mERs and meanwhile 
to preclude the possibility of mERs transportation to the cytoplasm site. Moreover, it also 
provides indirect evidence to confirm the presence of estrogen receptors in the plasma 
membrane site.  
6.2 Future perspectives 
            Dysfunction, damage and ageing of endothelium are key factors in the development of 
cardiovascular disease. Recently, endothelial progenitor cells (EPCs) based strategies have 
been emerged as a potential way for the repair and regeneration of damaged vessel.
[1, 2]
 To 
achieve this goal, various substrates for supporting the proliferation and differentiation of 
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EPCs to mature ECs, considered as extracellular matrix (ECM), are widely studied.
[3, 4]
 
Previous results suggested that CH-PC was capable of supporting the survival and 
amplification of EPCs.
[5]
 Moreover, administration of E2 at physiological concentration also 
influenced several physiological functions of EPCs, including regulation of cell cycle, 
apoptosis, proliferation and differentiation.
[6]
  In addition, E2 can also greatly enhance EPCs 
proliferation rate in vitro involved in the mitogenic effect of E2 as a consequence of the 
activations of MAPK signaling pathway.
[7, 8]
 The mechanism of E2 influence on EPCs 
proliferation is through triggering the reendothelialization process, which promotes the 
regeneration and recovery of the endothelium.
[9]
 Thus a synergistic effect of E2 and CH-PC in 
the CH-PC-E2 polymeric scaffold for supporting EPCs proliferation could be investigated in 
future study. Relevant mechanisms will also be explored and interpreted. Therefore, the 
collected knowledge may promote the applications of CH-PC-E2 hydrogel biomaterial as a 
platform for stem cell delivery in the vascular healing process. 
            On the other hand, more in vitro or in vivo studies of E2-functionalized micropatterned 
substrate could also be carried out. Multiple non-genomic signaling pathways, such as 
PI3K/AKT, can be justified by the E2-functionalized micropatterned substrate in vitro and 
enrich our knowledge of steroid biology. In addition, E2-functionalized micropatterned 
substrates are not only limited to cardiovascular medicine, but also expandable to solve the 
controversial issues in the other tissues or organs corresponding with genomic or non-genomic 
mechanisms. For example, administration of E2-dendrimer is an important therapeutic strategy 
in the treatment of osteoporosis mainly due to its non-genomic actions in osteobiology.[10] 
However, E2 non-genomic actions failed to decrease osteoporosis in vivo transgenic model 
studies.[11] In neurobiology, the non-genomic actions of E2-dendrimer or E2-BSA conjugates 
demonstrated protective effects and cognitive recovery against global cerebral ischemia in the 
hippocampal region although how this occurs still needs to be confirmed. Therefore, further 
investigations are required to clarify the precise roles of the non-genomic actions of E2 by 
using micropatterned substrates in bone or neural systems. Finally, one of the possible in vivo 
studies for E2-functionalized micropatterned substrate may focus on how to develop it as an 
implantable device in the cardiovascular system. By taking advantage of its unique non-
genomic nature, E2-functionalized micropatterned substrate will possibly perform as a 
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biosensor in the diagnosis, prevention and treatment of hormone related diseases. In sum, our 
E2-functionalized micropatterned will facilitate the study of more detailed profiles of 
fundamental steroid biology and advance the progress of clinical medicine.  
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